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ABSTRACT 
Lipopolysaccharides (LPS) are major structural· and virulence components of Gram-
negative bacteria. Antigenic and phase variation of LPS, the result of changes in 
carbohydrate composition and assembly of sugars in LPS, leads to increased cell surface 
diversity. A gene was isolated from Campylobacter jejuni and Campylobacter coli that 
had sequence identity to a phase variable gene, lex2B, from Haemophilus injluenzae. 
The lex2B shows sequence similarity to glycosyl and galactosyl transferases, however 
its function is still unknown. 
The aim of study was to characterise lex2B in C. jejuni and its potential role in 
pathogenesis of this enteric pathogen. Previous sequence analysis of C. coli strain M275 
revealed the presence of an ORF whose nucleotide sequence showed a high degree of 
similarity with lex2B from H injluenzae and H pylori. The lex2B gene from M275 was 
shown to be transcribed within aLPS biosynthetic locus, downstream of gmhA and in 
an opposite orientation to the waaF gene. Nucleotide sequence analysis of an 1.7 kb 
fragment from C. jejuni strain 928 contained in plasmid pDJ4216 revealed a common 
arrangement of genes, including lex2B, between C. coli and C. jejuni. The C. jejuni 
lex2B ORF was shown to consist of 765 nucleotides encoding a polypeptide of 255 
amino acids. Comparison of the C. coli and C. jejuni lex2B translated nucleotide 
sequence revealed strong variation in the second half of the protein. PCR and Southern 
analysis indicated that the lex2B gene in C. jejuni appears transcriptionally coupled to 
adjacent genes and physically linked on the genome to genes involved in biosynthesis of 
the LPS core. Expression studies based on production of lex2B rnRNA (RT-PCR) and 
expression of the putative Lex2B protein under transcriptional control of the T7 RNA 
polymerase in E. coli has shown that lex2B is capable of synthesing a polypeptide of the 
predicted size from sequence analysis. In order to create a null mutation in C. jejuni 928 
by homologous recombination, lex2B was cloned into pBluescript II containing a gene 
encoding resistance to kanamycin in Campylobacter. Based on evidence presented in 




1.1 DESCRIPTION OF THE GENUS 
Campylabaeter was initially classified as a member of the genus Vibria because of its 
morphology. In 1963 on the basis of different nucleotide base composition (mol% GtC) 
and its inability to utilise sugars either oxidatively or fermentatively, a new genus, 
Campylabaeter, was created. The genus Campylabaeter is classified in the family 
Spirillaceae (Veron and Chatelain, 1973). 
1.1.1 BASIC MORPHOLOGY AND PHYSIOLOGY 
Members of the genus Campylabaeter are spiral or helical rod shaped bacteria, 0.2 to 
0.9 ~m wide, 0.5 to 5 ~m long, Gram-negative and non-spore-forming (Nachamkin, 
1992). Members of the genus express polar, unsheathed flagella and are actively motile 
using a corkscrew-like motion (Cover and Blaser, 1989). Most Campylabaeter spp. 
require a micro aerobic atmosphere of 5-7% oxygen, 10% carbon dioxide and 80% 
nitrogen (Corry et al., 1995; Nachamkin, 1992). While members of this genus replicate 
across a wide temperature range, the human pathogens have an optimal growth 
temperature of 42°C. The so-called "thermophilic" Campylabaeter spp. are C. jejuni, C. 
cali, C. upsaliensis and C. lari (Ketley, 1995). 
Under certain stressful environmental conditions, such as exposure to atmospheric 
oxygen or nutrient limitation, Campylabaeter spp. undergo a transition in morphology 
from rods to round or coccoid forms (Ketley, 1995). This transition is associated with 
the onset of non-culturability on conventional laboratory media (viable non-culturable 
state (VNC)). 
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Members of this genus are important animal and human pathogens. However C. jejuni is 
believed to be responsible for 90% of all reported cases of human campylobacteriosis 
(Wallis, 1994; Stonnet and Guesdon, 1993). 
1.1.2 EPIDEMIOLOGY 
There are several natural animal reservoirs for Campyiobacter spp. The organism is a 
member of the endogenous intestinal flora of a wide range of birds and animals 
(Altelcruse et ai., 1994; Blaser and Reller, 1981; Faoagali, 1984; Rosef et ai., 1983). 
These include cattle, sheep, pigs, dogs, cats and poultry. C. jejuni has also been isolated 
from birds such as gulls, migratory ducks, domestic pigeons, crows and Canada geese 
(Kapperud and Rosef, 1983; Pacha et ai., 1988). The major means of transmission 
however, appears to be via faecal contamination. Potential sources for sporadic cases are 
hard to determine because of the fastidious nature of the organism and the delay in 
culture to tracking the source. 
Campylobacter spp. sources of infection have been extensively studied in New Zealand 
and internationally. Four sources account for nearly all epidemic cases: consumption of 
chicken and chicken products, unpasteurized mille, contact with pets and other animals, 
and impure water (Eberhart-Phillips et al., 1995). Other food sources implicated in 
transmission include mushrooms, watermelon, papaya, fish and shellfish (Castillo and 
Escartin, 1994; Wilson and Moore, 1996; Lacey, 1993). 
1.1.3 GENETICS OF THE GENUS Campylohacter 
Campyiobacter spp. have a small genome of about 1.6-1.8 Mb, an exception being C. 
upsaiiensis, with a genome of approximately 2.0 Mb (Bourke et ai., 1995). C.jejuni and 
C. coli chromosomal DNAs are only 36% of the size of the Escherichia coli 
chromosome (4.6 Mb) (Smith et ai., 1987). The chromosome of C. jejuni is circular and 
approximately 1.6 Mb (Karlyshev et al., 1998; Sanger centre, 1998). The chromosomal 
DNA of Campyiobacter spp. is typified as being extremely A+T rich, with an average 
G+C content of 30%. In comparasion, the E. coli G+C content is 50% (Nuijeten et ai., 
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1990; Chang and Taylor, 1990; Taylor, 1992; Kim et al., 1992; Kim et al., 1993). The 
small genome size of Campylobacter spp. is consistent with their small and fastidious 
nature; these organisms require numerous supplements for growth. Conjugative 
plasmids and bacteriopha~es have been reported in Campylo~acter and these 
extrachromosomal elements may contain essential genes required for metabolism 
(Taylor, 1992). 
1.2 Campylobacter AS A HUMAN PATHOGEN. 
Campylobacter spp. were fIrst recognised in the early decades of this century as a cause 
of infectious abortion and infertility in sheep and cattle. The first reported case of 
pathogenicity in humans was in 1947 (AlIos and Blaser, 1995). In 1972 after the 
development of selective stool-culture techniques, C. jejuni was. recognised as an 
important cause of acute diarrhoeal disease in humans (AlIos and Blaser, 1995). In 1980 
campylobacteriosis was made a notifIable disease in New Zealand and since then the 
incidence of infection has increas~d yearly (Faoagali, 1984). 
1.2.1 PATHOLOGY AND CLINICAL SYMPTOMS OF 
CAlVlPYLOBACTERIOSIS 
Once established, a campylobacter infection can manifest in several different ways. The 
vast majority of C. jejuni infections are gastrointestinal and usually self-limited, but 
extraintestinal infections including meningitis, urinary tract infections, reactive arthritis, 
Guillain-Barre syndrome (GBS) and Miller-Fisher syndrome (MFS) have been reported 
(Walker et al., 1986; Mishu and Blaser, 1994; Nachamkin et al., 1998). 
Gastroenteritis caused by Campylobacter spp. can last up to three weeks with an 
incubation period of 2-11 days. The clinical symptoms include diarrhoea (often bloody), 
nausea, fever, occasional vomiting, headache, malaise, muscular pain and acute 
abdominal pain (Stehr-Green et al., 1991; Eberhart-Phillips et al., 1995). Patients 
generally recover in seven days without treatment, but in up to 20% of cases a relapse or 
a prolonged illness occurs (Blaser et a!., 1983; Reina et a!., 1994). Generally hundreds 
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to thousands of bacteria are required for infection by C. jejuni. However, studies 
indicate that even low doses of C. jejuni can produce infection and illness in humans. In 
one milk-borne outbreak it was estimated that consumption of only 500 orgarlisms 
resulted in infection (Jones and Telford, 199Ib). In a separate study the minimum 
number of cells ingested by volunteers was 800 organisms, and this resulted in diarrheal 
illness in >50% of the samples (Black et ai., 1988). Conditions which reduce acidity in 
the stomach, such as surgery or peptic ulcer treatment, increase a person1s susceptibility 
to Campyiobaeter infection. Milk buffers gastric acid and thus fewer organisms are 
presumably needed for infection (Jones and Telford, 1991 b). 
Erythromycin remains the treatment of choice for most cases of campylobacteriosis. 
This agent is characterised by low toxicity, a relatively narrow spectrum of activity and 
ease of administration (Blaser and Reller, 1981; AlIos and Blaser, 1995). Ciprofloxacin 
has been used as an alternative treatment for acute diarrhoeal cases but bacterial 
resistance to this agent has increased (Lacey, 1993). C. jejuni strains are almost 
universally resistant to trimethoprim, cephalosporins, penicillin, vancomycin and 
rifampin (AlIos and Blaser, 1995). 
1.2.2 EXTRAINTESTINAL Campylobaeter DISEASE 
Extraintestinal diseases can occur as a result of C. jejuni infection. The incidence of 
C. jejuni penetrating the intestinal wall and invading a patient1s bloodstream resulting in 
bacteremia is speculated to occur in 0.15% of all intestinal infections (Nachamkin, 
1992; Lacey, 1993). Campylobaeter post-infection complications are infrequent but do 
occur and are often severe. They include neurological disease such as stroke, meningitis, 
empyema, encephalopathy andtwo polyneuropathic conditions, GBS and MFS (Yulci et 
ai.,1994). 
GBS has become the most common cause of acute generalised paralysis worldwide with 
annual incidence internationally of up to 2 cases per 100 000 population (Ropper, 1992; 
Mishu and Blaser, 1994). Up to two-thirds of GBS cases are preceded by symptoms of 
an infectious illness, most frequently of the respiratory or gastrointestinal tract (Rees et 
ai., 1993; Rees et ai., 1995). Campylobacteriosis is the most common antecedent event 
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associated with GBS. GBS usually occurs 1-3 weeks after bacterial or viral infections 
(Ropper, 1992). The mortality rate for GBS is 1-18% while 20% of cases suffer 
prolonged residual disability (Rees et al., 1993). 
GBS is an inflammatory, demyelinating disease of peripheral nerves. Speculation 
suggests that C. jejuni-induced GBS may arise due to the oligosaccharide portion of 
C. jejuni lipopolysacccharide (LPS). It has been observed that LPS from some 
serotypes of C. jejuni mimic the structure of human gangliosides. T and B cells 
stimulated in response to LPS post-Co jejuni infection secrete interleukins and stimulate 
macrophages (Nachamldn et ai., 1998). Macrophages and interleuldns are speculated to 
surround the endoneural vessels and cause demyelination of these neural structures 
(Lacey, 1993; Salloway et aI., 1996). Ganglioside-like structures have been identified at 
the terminal regions of LPS core oligosaccharides (OS) (Aspinall et aI., 1994b). OS 
structures which have human ganglioside GM1 and GDla structures have been found in 
serostrains HS:4, HS:19 and HS:41 (Aspinall et ai., 1992; Aspinall et aI., 1994b; Yuld 
et ai., 1994; Prendergast et ai., 1998) and GM2-lilce OS structures occur in LPS from 
serotypes HS:l, HS:23 and HS:36 (Aspinall et al., 1992). A C. jejuni strain of serotype 
HS:10, isolated from a patient suffering from MFS, had an OS structure reflecting the 
terminal region of human gangliosides Gm (Salloway et ai., 1996). Chemical analysis of 
LPS revealed that the core oligosaccharide had a terminal trisaccharide epitope 
consisting of two molecules of sialic acid (neuraminic acid) linked to galactose. This 
trisaccharide is not found in cores of non-neuropathic C. jejuni. A possible role of this 
trisaccharide in the etiology of neuropathies has been proposed (Salloway et al., 1996). 
1.3 VIRULENCE AND VIRULENCE FACTORS 
A reasonable understanding of the general clinical, microbiological and epidemiological 
aspects of C. jejuni infection has been achieved. However, the mechanisms by which C. 
jejuni induces disease are not well-understood (Ketley, 1995; Ruiz-Palacios, 1992). The 
bacterial virulence factors or determinants required to establish an infection are likely to 
be multifactorial in nature. Common mechanisms postulated for bacterial-induced 
illness include: adherence, production of enterotoxins, replication, colonisation and 
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resistance against host defences (e.g., lysozyme, phagocytes, complement). Additionaly 
some microorganisms, such as C. jejuni, must invade and proliferate within the 
intestinal epithelium. This results in cellular damage and activitation of the host 
inflammatory response (Ruiz-Palacios, 1992; Ketley, 1997; Cover and Blaser, 1989). 
In this section I will discuss factors produced by C. jejuni that are implicated or proven 
to be important for the pathogenicity of the organism. These factors (flagella, outer 
membrane proteins (OMPs), LPS, cytotoxins and iron aquisition) are briefly examined 
below. 
1,3.1 CHEMOTAXIS AND MOTILITY 
Effective colonisation of host tissues requires chemotaxis. Campylobaeter possesses 
cellular mechanisms that detect chemical gradients and have linked motility functions 
that enable the cells to move up or down the gradient. Hugdahl et al. (1988) have 
demonstrated that several host cell molecules may be chemoattractants, including 
mucin, L-serine and L-fucose, while several bile acids have chemorepellant effects. 
However, little is known regarding the molecular basis of Campylobaeter chemotaxis. 
One regulatory ,protein, CheY, has been characterised. Alterations in the amount of 
Che Y, a protein that mediates clockwise rotation of flagellum, affects in vitro invasion 
and in vivo virulence (Yao et al., 1997). 
Colonisation requires flagella, the best characterised virulence determinants of C. jejuni 
(Ketley, 1995). Aflagellated mutants and flagellated nonmotile C. jejuni strains cannot 
colonise animal models (Taylor, 1992; Wallis, 1994; Ketley, 1997). C. jejuni flagella 
are unsheathed and demonstrate phase and antigenic variation. Flagella are also highly 
immunogenic, with patients producing antibodies to the flagella shortly after infection 
(Taylor, 1992). Phase variation refers to a bi~directional transition between flagellated 
and aflagellated phenotypes. Mutation analysis revealed that these modifications of 
flagellin may playa role in the protective immune response (Guerry et al., 1996; Ketley, 
1997). Phase and antigenic variation may alter the ability of a bacterium to invade host 
cells and to resist killing by antibodies and complement (Moran et al., 1994; van Putten, 
1993; Weiser et al., 1989). Reported mechanisms for phase and antigenic change are 
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slipped strand mispairing (Kimura and Hansen, 1986; Moxon and Maskell, 1992; Cope 
et al., 1991; Preston et al., 1996; Inzana et al.; 1997) and post-translation modification 
of the flagellin protein by glycosylation (Constantinidou et a!., 1996; Doig, et al. 1996). 
1.3.2 ADHESINS 
The ability of many pathogenic bacteria to bind to non-professional phagocytic cells is 
an important virulence determinant as it prevents the colonising bacteria from being 
swept away by mechanical cleansing forces such as peristalsis and fluid flow. Bacteria 
adhere only to complementary surfaces, and adherence involves an interaction between 
structures on the surface of bacterium (adhesins) and receptors on the substratum. 
Adhesins are proteins that engage in protein-carbohydrate or protein-protein 
interactions, targeting structures contained in matrix glycoproteins, integral membrane 
glycoproteins, or glycolipids (Cundell and Tuomanen, 1995). It remains formally 
possible that adhesins are carbohydrates that engage cognate carbohydrates, as 
suggested in a few eucaryotic interactions (Turley and Roth, 1980). Possible adhesins 
include Omps, flagellae and LPS (McSweegan and Walker, 1986). 
Using a ligand binding assay, De Melo and Peche're identified four Omps that may play 
a role in mediating C. jejuni binding to host cells (be Melo and Peche're, 1990). One 
Omp, of a 28 IcDa periplasmic binding protein (PEB 1), is involved in amino acid 
transport (pei and Blaser, 1993). Several authors have reported PEBI as the major 
adherence factor conserved in all C. jejuni and C. coli isolates, but all studies have so far 
lacked in vivo evidence of this (Burnes et al., 1995; Gavis et al., 1996). Recently 
Konkel and colleagues identified an adhesin termed CadF ([;.ampylobacter adhesion to 
jibronectin). The CadF protein is conserved among C. jejuni and C. coli isolates 
(Konkel et al., 1997; Konkel et a!., 1999a). It is speculated that binding of C. jejuni to 
fibronectin is an important early event that leads to successful colonisation. Following 
binding, C. jejuni would have sufficient time to synthesise the proteins required to 
facilitate intemalisation. Production of fimbriae has not been observed in C. jejuni 
(Walker et ai., 1986) but production of an environmeta1ly regulated pilus-like 
appendage has been reported in response to bile rich environments (Doig et ai., 1996). 
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There is some evidence that flagella also function as an adhesin, enabling C. jejuni to 
attach to epithelial cell surfaces (Field et al., 1993; McSweegan and Walker, 1986). 
Other researchers have refuted this fmding (Ketley, 1995; Konkel and Klena, 1995). It 
has been speculated that C. jejuni adhesion to host cells may not be necessary as the 
bacterium is able to remain highly motile in mucus (McSweegan and Walker, 1986; 
Ketley, 1995). 
McSweegan and Walker suggested that LPS may be an important adhesin. Their results 
indicate that the short 0 side chains of C. jejuni strain HC were important in mediating 
contact with INT 407 epithelial cells. LPS was extracted from radiolabelled C. jejuni 
and used in an INT 407 cell adhesion assay. Results showed that LPS specifically bound 
to cells, suggesting the role of LPS in attachment to epithelial cells. Periodate oxidation 
of LPS reduced the binding of Campylobacter to cells, suggesting that the binding is 
through the carbohydrate portion of the LPS molecule (McSweegan and Walker, 1986). 
Purified LPS from the C. jejuni strain HC was also effective in blocking the attachment 
of intact He cells to INT 407 cells. 
1.t AVOIDANCE OF IMMUNE SYSTEM 
1(3.3.1 Resistance to complement-mediated kHling 
Th~\mplement system plays a key role in response of the host to microbial invasion 
and inf\tion. A large number of Gram-negative bacteria are susceptible to complement-
mediated\1911ing, and exposure of these cells to a suitable source of complement, such as 
serum or plasma, may lead to a rapid and efficient reduction in viability (Taylor, 1995). 
Killing is sometimes accompanied by lysis of the target bacteria by lysozyme. LPS 0 
side chains are implicated as a major structural determinant for complement resistance 
(Joiner, 1985). Mutations resulting in transition from 0+ to 0- phenotypes lead to large 
increases in complement susceptibility (Gamian et al., 1992). Gram-negative organisms, 
which have smaller or nonexisting 0 antigens, use other carbohydrate structures for 
complement resistance. For example, phase variation of surface antigens is a common 
theme for some bacteria to evade the immune system (e.g., Haemophilus injluenzae 
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(Moxon and Maskell, 1992; Jarosik and Hansen, 1994), H somnus Onzana et al., 1997), 
Neisseria meningitis and Neisseria gonorrhoeae (van Putten, 1993). One genetic 
mechanism for LPS phase variation is based on slipped strand mispairing. Gene loci that 
have highly repetitive DNA sequences are subject to slipped-strand mispairing, causing 
recombination-independent deletions or insertions of entire repeat units (Levison and 
Gutman, 1987). It is believed that other mechanisms are also responsible for variation 
such as LPS sialylation (Mandrell et al., 1993; Rest and Mandrell, 1995). How 
Campylobacter avoids complement-mediated killing is still unknown. C. jejuni and C. 
coli are generally serum-sensitive in the absence of specific antibody, but isolates from 
blood are less sensitive than those from stool (Walker et al., 1986). Complement-
opsonized C. jejuni are efficiently killed by polymorphonuclear leucocytes, whereas 
without complement-opsonisation, phagocytosis is less efficient and strain dependant 
(pennie et ai., 1986; Walan et aI., 1992; Autenrieth et ai., 1995). Possible factors used 
to evade complement are variation in structure of LPS (core sugars and O-antigen) and 
LPS sialyation (van Putten, 1993). 
C. jejuni antigen variation and invasion 
C. jejuni LPS consists of a low molecular weight fraction and in some cases it may also 
contain a high molecular weight fraction (preston and Penner, 1989; Mills et ai., 1992; 
Aspinall et ai., 1992). Many C. jejuni serovars , e.g., HS:1, HS:2, HS:4, HS:19, HS:23, 
and H:36, do not display LPS with an extensive 0 side chain (Aspinall et ai., 1994; 
Yuki et aI., 1994). The presence of a rough LPS phenotype in C. jejuni may be a 
significant factor for its ability to colonise the epithelium, Unlike strains with a smooth 
LPS phenotype (Ketley, 1997; McSweegan and Walker, 1986). The basolateral 
epithelial cell surface of the intestine appears to be the preferred binding site of both the 
flagellum and LPS, suggesting that the epithelial cell surface contains better 
Campyiobacter receptors than does the intestinal mucus (McSweegan and Walker, 
1986). Campylobacter may cross the intestinal epithelium by translocation or epithelial 
cell invasion followed by cell lysis (Konkel et aI., 1992). An additional epithelial 
translocation pathway could be via M cells (Walker et ai., 1988; Walker et ai., 1992). 
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After colonisation of the mucus, Campylobacter cells disrupt the normal absorptive 
capacity of the intestine by damaging epithelial cells either by cell invasion, the 
production of toxin(s) , or both (Wallis, 1994). The occasional bacteraemia case (ladron 
de Guevara et aI., 1994), and inflammation of the intestine strongly suggest that cell 
invasion is an important pathogenic mechanism. Recently Konkel et al. (1999b) have 
identified a protein required for C. jejuni internalisation by non-professional phagocytic 
cells. This protein, CiaB, may be secreted into INT 407 cells via a type III secretion 
system that stimulates host cell signalling and triggers bacterial internalisation (Konkel 
et aI., 1999b). A null mutation in ciaB results in a non-invasive phenotype and abolishes 
the secretion of all contact-dependent secretory proteins. 
The role of the flagella in colonisation and invasion has been confirmed with defmed 
genetic mutants (Taylor, 1992; Nachamlcin et al., 1993; Wassennaar et al., 1993; Yao et 
at., 1994). The flaAflaB" mutants demonstrated >55% reduction in adhesion and 97% 
reduction of invasion into tissue culture cells comparing with wild types. The ptlA 
(paralysed flagella) mutants showed abberation in flagellar structure at the point at 
which the filament attaches to the cells. These mutants displayed the same, non-invasive 
phenotype, as ciaB- with the level of adhesion just two fold reduced (Yao et at., 1994; 
Konkel et al., 1999b). This indicated that Campyiobacter invade by processes requiring 
active motility. 
1.3.3.2 Toxins and nutrient aquisition 
Toxins may also contribute to the disease process. C. jejuni isolates have been reported 
to produce various toxic activities, including a heat labile enterotoxin and several 
cytotoxins (Walker et ai., 1986; Suzuki et at., 1994), including a cholera-1ilee toxin, 
cytolethal distending toxin, a shiga-like toxin and an haemolysin (Wallis, 1994; Ketley, 
1995). However, other studies have questioned the significance of these findings 
(Konkel et al., 1992). 
LPS is an essential component of bacterial cell-associated toxins (endotoxins) 
(Schnaitman and Klena, 1993; Raetz, 1993). Endotoxins can elicit disease symptoms 
ranging from chills and fever to irreversible shock and death. Paradoxically, these same 
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endotoxins can enhance the body's overall immune resistance to bacterial and viral 
infections and cancer (Rietschel and Brade, 1992). The lipid A moeity possesses the 
majority of the endotoxic activities associated with LPS. 
In order to colonise the intestine, Campylobacter must be able to compete with resident 
flora for nutrients, including iron, and avoid the host immune defences. Iron is an 
essential element for all living organisms and pathogenic bacteria must obtain iron 
throughout the infectious process. In host tissues, the availability of iron is very low, as 
most iron is complexed with host proteins such as hemoglobin and transferrin. 
Campylobacter have not been shown to produce siderophores (specific chelators for 
ferric ions), but they are able to use exogenous siderophores (Field et ai., 1986; 
Richardson and Park, 1995). Iron homeostasis in C. jejuni is under the regulation of the 
Fur protein as it is in most Gram-negative bacteria (Wooldridge et ai., 1994; van Vliet et 
ai., 1998). The growth rate of a C. jejuni fur mutant has been shown to be reduced 
compared to that of the wild-type under both low- and high-iron conditions (van Vliet et 
ai, 1998). 
1.4 OVERVIEW OF LIPOPOLYSACCHARIDE 
The surface of Gram-negative bacteria is an important entity in environmental and host-
parasite interactions. The outer membrane protects cells from the detergent action of 
bile salts, degradation by digestive enzymes present in intestinal tracts and antibiotics 
(Nikaido and Vaara, 1985). Another important function of the outer membrane is to 
endow the bacterial surface with strong hydrophilicity. This is an, important feature 
which enables cells to evade phagocytosis, complement, and to avoid specific immune 
attack (Nikaido and Vaara, 1985). LPS are essential components of the outer membrane 
of Gram-negative bacteria; they are the immunodominant antigens on cellular surfaces, 
and are the major constituent of bacterial endotoxin (Stanier et ai., 1984). 
LPS molecules are conserved in overall structure. LPS is composed of three functional 
domains, a hydrophobic glycolipid lmown as lipid A that anchors the LPS to the outer 
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membrane, a hydrophilic non-repeating core OS consisting of an inner and outer region, 
and a distal repeating polysaccharide, known as the 0 polysaccharide, presented at the 
cell surface (Reeves, 1994a). Lipid A and the core OS are synthesised and translocated 
together as a single unit which serves as an acceptor for pre-fanned 0 antigen to yield 
the completed LPS molecule (Whitfield, 1995). 
1.5 BIOCHEMISTRY AND ORGANISATION OF LPS 
BIOSYNTHETIC GENES 
Enterobacteriaceae polysaccharide biosynthetic pathways that have been studied at a 
genetic level are characterised by the organisation of biosynthetic genes into loci 
consisting of one or more operons (Daniels et.al., 1992; Jiang et.al., 1991; Schnaitman 
and Klena, 1993). Each loci contains most of the genes that are necessary for the 
synthesis of the corresponding component of a particular polysaccharide. Several loci 
such as these have been found (Figure 1). In addition to the waa and wba loci for LPS 
biosynthesis, these include the wec gene loci, which is comprised of genes encoding 
enzymes for the biosynthesis of the enterobacterial common antigen (ECA) (Daniels 
et.al., 1992), and the cps and kps gene loci, comprised of genes encoding enzymes 
involved in the synthesis of type I capsules such as colanic acid (Keenleyside et.al., 
1993) and type II capsules (Reeves et.al., 1996). In this section I shall briefly discuss the 
gene loci of E. coli K12, S. typhimurium LT2 and C. jejuni that are involved in LPS 
biosynthesis, and their organisation. 
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Figure 1. Composite genetic map showing approximate locations of genes and gene loci (solid blocks) 
involved in LPS biosynthesis that have been identified in E. coli and S. typhimurium. Numbers indicate 
position in minutes. This map has been modified to accommodate the different genetic maps of these two 
organisms (Adapted from Schnaitman and I<lena 1993; gmhA gene position mapped with information 
from Brooke 1996) 
1.5.1 LIPID A 
Lipid A is a non-conventional hydrophobic glycolipid. Lipid A of E. coli and S. enterica 
sv. Typhimurium LT2 (hereafter referred to as S. typhimurium LT2) is a ~,1-6 linked 
disaccharide ofN-acetylglucosamine (GlcNAc) to which five or six fatty acid residues 
are attached through amide and ester linkages, respectively (Figure 2) (Raetz, 1993). 
The unique amide-linked fatty acids are 3-hydroxytetradecanoic acids; however, these 
may be replaced by other 3-hydroxy acids or 2-hydroxy fatty acids in other Gram-
negative bacteria such as Brucella spp. (Nikaido and Nakea, 1979), Pseudomonas 
aeruginosa (Raetz, 1990), Neisseria gonorrhoeae (Goldman et.al., 1987; Talcayama 
et.al., 1986). Fatty acids isolated from C. jejuni were 3-hydroxytetradecanoic, 
hexadecanoic and tetradecanoic acids (Comad and Galanos, 1990; Moran et.al., 1991a; 
Aspinall et.al., 1995). Genes encoding several of the enzymes known to be involved in 
lipid.A biosynthesis are located in a small cluster of 11 genes organised into a complex 
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operon, which has been termed the macromolecular synthesis II operon (Coleman and 
Raetz, 1988). Three of the genes for lipid A biosynthesis, lpxA, lpxB and lpxD map to 4 
mlnutes with JabZ and several other genes involved in macromolecular synthesis 
(Reeves, 1994b). Sequence analysis of C. jejuni lpxA and JabZ suggests that the 
essential order of these genes is the same as in E. coli K12 (Ibbitt, 1997). Other E. coli 
genes such as dnaE (encoding the a. core subunit of DNA polymerase III) also map to 
this operon. Another gene, IpxC (previously known as envA) whose product is lmown to 
be involved in lipid A biosynthesis is located (2 min) in a gene cluster encoding for 
enzymes involved in cell division (Reeves, 1994b). 
Figure 2. Carbohydrates that compose lipid A and inner core regions of enteric bacteria and genes 
involved in their synthesis. The lipid A-inner core region is a composite of E. coli K12 and S. 
typhimurium structures. 
Abbreviations: 
BHM =~-hydroxymyristate; FA12=laurate; FA14=myristate; P=phosphate; 
PEA= phosphorylethanolamine; PPEA =pyrophosphorylethanolamine; GlcN =glucosamine; 
AraN =4-aminoarabinose 
The lipid A component of C. jejuni LPS has unusual chemical properties in comparison 
with that of E. coli and Salmonella spp. Using high voltage paper electrophoresis, 
serological, structural and chemical techniques, structurally unique lipid A molecules 
containing monosaccharide or disacccharide backbones composed of other amino sugars 
such as 2,3-diamino-2,3-dideoxy-D-glucose (GlcN3N) or glucosaminuronic acid 
(Weckesser and Mayer, 1988) have been characterised. C.jejuni lipid A contains both 
GleN and GlcN3N (Moran et.al., 1991 b; Moran, 1995). Previous work by Moran and 
coworkers has shown that C. jejuni LPS contains three lipid A backbones composed of 
GleN-GleN, GlcN3N-GlcN3N, and a hybrid disaccharide GlcN3N-GlcN (Moran, 1995). 
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Changes in the molecular structure of lipid A due to diaminoglucose substitution of the 
hydrophilic backbone and length of the non-hydroxylated fatty acids residues attached 
to lipid A may lower the endotoxic potency ofthe C. jejuni LPS molecule. 
1.5.2 OLIGOSACCHARIDE CORE 
The hydrophilic non-repeating oligo saccharides of most Gram-negative bacteria studied 
have an inner domain composed of KDO and L-glycero-D-mannoheptose (Rep) to 
which an outer domain composed of hexoses (e.g., glucose, galactose) and GlcNAc is 
sequentially added. Phosphate and phospho ethanolamine moieties may also be present 
in sub stoichiometric amounts (Reeves, 1994b). 
1.5.2.1 Inner domain 
The inner core is highly conserved across diverse genera. Campylobacter are no 
exception to this rule. Among all C. jejuni serotypes the inner domain is conserved and 
contains a Hep-1(p-D-Glucose 1-4 linked branch)3-Hep-1-5-KDO linkage (Aspinall 
et.al., 1993b). 
KDO 
Attached to the non-reducing end of lipid A is the OS core region. The core is 
functionally divided into an inner and outer portion. The inner core is composed of at 
least two residues of 3-deoxy-D-manno-octulosonic acid (KDO) usually followed by 
two residues· ADP-L-glycero-D-mannoheptose (ADP-Hep) (Sirisena et.al., 1992; 
Schnaitman and Klena, 1993). The eight-carbon acid lCOO is linked 0.(2-6') to the lipid 
A disaccharide (Figure 2). This attachment is catalysed by the enzyme KDO transferase, 
which is encoded by the waaA gene in E. coli (Belunis, 1995). In E. coli, strains that are 
defective in lipid A or lCOO biosynthesis have been isolated as conditional . lethal 
mutants, suggesting the minimal structure for survival is lipid A-KDO. An H injluenzae 
mutant, Rd:169, lacking all core sugars except a single phosphorylated lCOO, has been 
characterised. This mutant is able to grow at normal rates in vitro despite having the 
"roughest" LPS described to date (Zarnze et.al., 1987). 
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In contrast to other LPS biosynthetic loci, genes involved in the biosynthesis of I<DO 
(kdsA, kdsB and waaA) are unlinked on the E. coli chromosome even though their gene 
products take part in the same biosynthetic pathway (Schnaitman and Klena, 1993). 
kdsA is transcribed from its own promoter located at approximately 27 min. The kdsB 
gene maps to 84.7 minutes and is thought to be the proximal gene of another small 
operon (Goldman et.al., 1987). The waaA gene encoding the KDO transferase is located 
at the end of the waa cluster at approximately 81 minutes (Belunis, 1992; Schnaitman 
and Klena, 1993). 
KDO is a promising target in the design of novel antibacterial agents as the presence of 
KDO has not been reported in mammalian cells (Hammond et.al., 1987). 
Heptose 
The presence of two or more Hep residues in the inner core is highly conserved in 
Gram-negative bacteria. ADP-Hep molecules are added sequentially to KDO I of the 
newly synthesised KD02-Lipid A. Attachment of Hep I is through an a glycosidic 
linkage at position 5 of KDO I, while the second Hep is attached a(1-3) to Hep I. A 
branch Hep, Hep III, if present, is linked a(1-7) to Hep II by a specific LPS heptosyl 
transferase (Reeves, 1994b). At least seven genes have been identified whose products 
are involved in the synthesis of the heptose region of the LPS core of S. typhimurium. 
These include four structural genes involved in biosynthesis of Hep (gmhA, gmhB, 
gmhC, gmhD), three heptosyl transferases (waaC, waaF, waaQ) and genes waaP and 
waaY whose products are necessary for LPS phosphorylation and crosslinking (Parker 
et.al., 1992; Heinrichs et.al., 1998a). 
Eidels and Osborn (1971) were the first to propose a biosynthetic pathway for ADP-
Hep. This pathway is composed of four enzymatic steps and requires sedoheptulose-7-P, 
a product of the pentose phosphate pathway (Eidels and Osborn, 1971). According to 
Eidels and Osborn, the conversion ofsedoheptulose-7-P to D-glycero-D-mannoheptose-
7-P occurs by a phosphoheptose isomerase. Conversion of D-glycero-D-mannoheptose-
7-P to D-glycero-D-mannoheptose-1-P by a phosphoheptose mutase is proposed as the 
second step of the pathway. D-glycero-D-mannoheptose-1-P is charged with ATP 
Chapter I Introduction 17 
generating ADP-D-glycero-D-mannoheptose and pyrophosphate (PPi) by an ADP-Rep 
synthase. In the last step racemisation by an epimerase changes ADP-D-glycero-D-
mannoheptose to the ADP-L-glycero-D-mannoheptose isomer. The completed Rep 
molecule is then used as a substrate for addition to inner core by a specific heptosyl 
transferase (Eidels and Osborn, 1974; Brooke, 1996). 
A phosphoheptose isomerase encoded by the gmhA catalyses the first step in Rep 
biosynthesis in E. coli, C. jejuni and C. coli (Brooke, 1996; Upritchard, 1997). The 
gmhA gene maps to 5.3 minutes on the E. coli chromosome, distal to the 
macromolecular II synthesis operon (Brooke, 1996). The translated gmhA amino acid 
sequence shows similarity to a family of conserved aldo/keto isomerases. The GmhA 
from C. coli strain M275 has 62% identity with E. coli GmhA and 92.3% identity with 
C. jejuni strain NCTCI1168 (Upritchard, 1997). The organisation of gmhA on the C. 
jejuni and C. coli chromosome appears to be different to that reported for E. coli and H 
injluenzae. IIi C. coli M275, gmhA is linked downstream to a gene Imown as lex2B (a 
putative hexosyl transferase) and waaF (heptosyl transferase II). This arrangement is 
novel and has not been reported for any other Gram-negative organism to date 
(Upritchard, 1997). The presence of lex2B in this arrangement is a variable feature for 
C. jejuni and C. coli isolates. Sequence analysis revealed the absence of lex2B in some 
isolates of C. jejuni (e.g. NCTC11168 strain) (Upritchard, 1997; Sanger centre, 19982. 
In other bacteria such as H injluenzae (Jarosik and Hansen, 1994), H somnus (Inzana 
et.al., 1997), N. gonorrhoeae (Erwin et.al., 1996), N. meningitis (Jennings et.al., 1995) 
and H pylori (Alm et.al., 1999), the lex2B homolog is always present on the 
chromosome and has been shown to playa role in LOS phase variation. 
The genes waaC, waaF, and waaQ have been identified as encoding heptosyl 
transferases I, II, III for transfer of Rep to the inner core (Siresena et.al., 1994; 
Heinrichs et.al., 1998b). Reptosyl transferase I is encoded by the waaC gene and is 
responsible for addition of the a(I-5) linked Rep I residue to KDO I in E. coli (Chen 
and Coleman, 1993), S. typhimurium (Sirisena et.al., 1992) and C. jejuni and C. coli 
(Klena, 1998). In vitro evidence revealed that mutants in waaC contained an ADP-Rep 
precursor but isolated LPS lacked Rep and was structurally identical to KD02-lipid A. 
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Functional interspecies complementation has demonstrated that waaC isolated from E. 
coli and transfer into defective S. typhimurium and H injluenzae waaC mutants, 
rebuilds full LPS (Sirisena et.al., 1992; Chen and Coleman, 1993). The waaC gene 
isolated from C. jejuni and C. coli successfully restores full length LPS in S. 
typhimurium waaC mutants (Klena, 1998). This suggests the proteins are functionally 
conserved and biosynthesis of Campylobacter LPS occurs by a similar mechanism to 
that of the enteric LPS. 
The waaF gene has been identified as encoding heptosyl transferase II which adds the 
second a(1-3) linked heptose to the main Iiascent chain of the inner core (Schwan et.al., 
1995; Sirisena et.al., 1994)~. Point mutations in the waaF gene of S. typhimurium LTI 
result in production of LPS with a single Hep attached. These mutants are able to 
synthesize Hep as indicated by the presence of attached Hep. A cloned gene capable of 
restoring expression of wild type LPS in a S. typhimurium L TI mutant deficient in 
heptosyl transferase II has been isolated from N gonorrhoeae (Schwan et.al., 1995), E. 
coli (Schnaitman and Klena, 1993) and C. jejuni (J.Klena per. comm.). 
The waaQ encodes heptosyl transferase III for third branch a(1-7) linked Hep to Hep II. 
The protein shows a clear region of homology with the waaC and waaF proteins 
(Sirisena et.al., 1994; Yethon et.al., 1998). To date, a waaQ homolog has not been 
characterised from Campylobacter. The third branch heptose as found in E. coli and 
Salmonella spp. appears to be absent in C. jejuni. 
Phosphorylation o/the inner core 
Phosphorylation of ICDO and Hep residues is considered to be an important feature for 
outer membrane permeability. The phosphoryl substituents in the heptose region are 
critical for ensuring outer membrane stability because the negative charge allows 
neighboring LPS molecules to be cross-linked by divalent cations. One gene of reported 
importance is waaP. Mutation analysis suggests that WaaP, by adding PPEA to Hep I, 
enables bacteria to keep the outer membrane impenetrable towards other hydrophobic 
compounds. Mutation of waaP resulted in loss of phosphoryl substituents on Hep I and 
obviated WaaQ and WaaY activity (Yethon et.al., 1998). The waaP gene has been 
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cloned and sequenced from E. coli (parker et.at., 1992), S. minnesota (Jousimens and 
Makela, 1974) and S. typhimurium. The WaaY protein is another important 
phosphokinase that is involved in phosphorylation on Hep II. Phosphorylation of Hep II 
by Waa Y requires transfer of Rep III (function of WaaQ) and phosphorylation of Hep I 
(Yethon et.at., 1998). 
1.6 ORGANISATION WITHIN LPS GENETIC LOCI 
Hydropathy profiles suggest that few genes in the waa locus of S. typhimurium or E. 
coli encode membrane spanning proteins (Schnaitman and IUena, 1993). Gene products 
in this locus are almost exclusively soluble or membrane associated proteins, with no 
signal sequences typical of proteins translocated into the periplasm or outer membrane 
(Raetz, 1990). This supports the hypothesis that LPS is synthesized on the cytoplasmic 
face of the cytoplasmic membrane. Essential sugar nucleotides such as ATP and R-3-
hydroxy-myristoyl-ACP are located in the cytoplasm. 
In at least two members of the family Enterobacteriaceae most of the genes in the waa 
cluster are strongly conserved. The waa gene locus maps to 81 minutes on the E. coli 
chromosome and 79 minutes on the S. typhimurium chromosome (Bachman, 1990; 
Rocero and Casadaban, 1992). The cluster in E. coli K12 consists of a minimum of 17 
genes while the S. typhimurium cluster has at least 13. The arrangement of the genes 
within the two loci appears to be highly conserved (Schnaitman et.at., 1991; Schnaitman 
and KIena, 1993). Products of waaBCDFGPQYZ genes all exhibit 70% or more amino 
acid identity between E. coli and S. typhimurium in addition to their organisational 
conservation. waaBCDFGQSZIJ genes encode glycosyl, galactosyl or GlcN transferase. 
In general, the predicted amino acid sequences of genes located toward the centre of the 
waa gene locus appear less strongly conserved between genera (Schnaitman and Klena, 
1993) or even within a species (Reeves et.al., 1994a). This phenomenon in gene locus 
conservation may have arisen from a series of ancestral genetic exchanges involving 
very dissimilar organisms (Reeves et.at., 1994a). 
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1.6.1 OUTER CORE DOMAIN 
The outer core sugars glucose and galactose are sequentially attached to an al,3-linlced 
main chain Hep of LPS (Figure 3) to provide the structural framework for the outer, or 
hexose, region of the core (Schnaitman and Klena, 1993). The outer core region shows 
diversity with respect to the type of sugars present and the linlcages by which they are 
joined. In E. coli, WaaGBORK., and S. typhimurium, WaaGBIlK, proteins are sugar 
transferases (Schnaitaman and Klena, 1993; Heinrichs et.al., 1998). They share limited 
regions of sequence identity and appear to have a similar secondary structure. The 
galactosyltransferases are WaaI, which adds UDP-Gal to a(1-3)Glu IT in S. 
typhimurium, and WaaB involed in attachment of UDP-Gal to a(1-6)Glu IT in E. coli 
and S. typhimurium. Glucosyltransferases include waaGO(l)R(J). The waaG product 
transfers the fIrst outer core sugar, glucose I (UDP-glucose), to the inner core Hep II 
residue. waaG has been characterised in both E. coli (parker, 1992) and S. typhimurium 
(Reeves et.al., 1994b). 
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Figure 3. Simplified schematic overview of the outer core OS of E. coli K12, S. typhimurium LPS. Due 
to the heterogeneity in the chemical structures of LPS, the structures shown represent an average or 
consensus structure rather than a distinct molecular species. 
In C. jejuni, galactose (linlced /31-3) is the next addition on the chain after heptose II. 
However, D-glucose may instead be substitutied (Figure 4)(Aspinall et.al., 1992). 
Other additions to the outer core and branches on the entire oligosaccharide appear to be 
variable in respect to the sequence of sugars, linkage types, anomeric confIguration and 
degree of phosphorylation (Aspinall et.ai, 1993a; Aspinall et.al., 1993b). Unexpected 
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constituents such as sialic acid (N-acetyl neuraminic acid (Neu5Ac» and 3-amino-3,6-
dideoxy-D-glucose (Qui3N) have been located in some serotypes as branch or chain 
derivatives in the outer core (Aspinall et.al., 1995). Neu5Ac is chemically related to 
KDO but is rarely found in procaryotes. When present it generally occurs as chain-
linked polymer component of the capsular polysaccharide of E. coli K1 and K92 
capsules, N meningitidis (Vogel et.al., 1997). N gonorrhoeae (Mandrell et.al., 1990), 
Salmonella tourcra (Keclzierska, 1978), Rhizobium meliloti (Defives et.al., 1989) and 
Rhodobacter spp. (Krauss et.al., 1988). Neu5Ac has low or no immunogenicity due to 
structural mimicry of mammalian host gangliosides. This may play a part in 
complement-mediated resistance (Moran et.al., 1991a; Preston et. al. , 1996). The 
presence of Neu5Ac may cause increased resistance· to human serum but the 
significance in C. jejunipatbogenesis in enteritis cases is uncertain (Salloway et.a/., 
1996). 
Figure 4. Strucure of the core as from C.jejuni serotype HS:l 
After addition of the last glucose in the core OS of E. coli K12 and S. typhimurium L T2, 
LPS structures differ. Genes encoding a glycosyl transferase responsible for addition of 
side chain saccharide moieties are thought to be waaS and waaZ in addition to waaK 
and waaL. The waaK product is an N-acetylglucosaminyltransferase involved in 
addition of a GlcNAc residue to the terminal core glucose in S. typhimurium 
(MacLachlan et.ai., 1991) and the inner LPS core in E. coli (Klena and Schnaitman, 
1994). Attachment of GlcNAc (or glucose in E. coli K12) is a prerequirement for 
. successful ligation of the 0 polysaccharide (Yethon et.ai., 1998). The ligase enzyme is 
envisioned as a glycosyltransferase, encoded by waaL, with a complex (lipid-linked 
oligosaccharide) substrate requirement (Reeves et.al., 1994b; Whitfield, 1995). The role 
of WaaS and WaaZ is presently unknown, but their involvement in alteration of LPS is 
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clear. Data so far indicates that WaaS is involved in modification of 0 polysaccharide 
by adding TDP-Rhamnose to the nascent chain (Schnaitaman and IUena, 1993). 
1.6.2 0 ANTIGEN 
The rjb gene locus maps to the 44-48 minute region in S. typhimurium, and to the 44 
minute region of E. coli K12. This cluster contains genes that encode enzymes involved 
in 0 antigen subunit synthesis and polymerisation (Schnaitman and Klena, 1993). 
Biosynthesis of the 0 polymer occurs in association with the carrier lipId enzyme 
bactoprenyl pyrophosphate. 
Detailed structural studies of the high M~PS from C. jejuni serotypes HS:19, HS:23 
and HS:36 have demonstrated the presence of O-antigen chains that mirror O-antigens 
associated with "smooth" type LPS of Salmonella spp. (Mills et.al., 1992). Each 0 
polysaccharide contains repeating units in which two of the three residues (N-acetyl-
glucosamine and galactose) are always identical but the third sugar residue is one of 
four similarly linked and stereo chemically related Hep sugars (Mills et.al., 1992). The 
point of attachment of the O-antigen side chain in C. jejuni is speculated to be in KDO 
or heptose region of the inner core, not the distal end of ,oligosaccharide as is the case 
with Salmonella spp. (Aspinall et.al., 1994c). 
1.7 OBJECTIVE OF THIS STUDY 
Antigenic and phase variation caused by the lex2B gene in H injluenzae type b alters 
virulence (Jarosik and Hansen, 1994). An ORF downstream of gmhA in C. coli strain 
M275 was shown to have strong similarity with lex2B in H injluenzae (Upritchard, 
1997). In C. jejuni strain NCTCI1168 the presence of lex2B nucleotide sequence has 
not been detected, however a similar ORF is present in strain C. jejuni 928. The 
objective of this study has been to isolate and characterise lex2B from C. jejuni 928 and 
its potential role in pathogenesis of the organism. To accomplish this, identification of a 
functionallex2B gene in C. jejuni strain 928 and characterisation of both the gene and 
its product at a genetic and enzyme level as time permitted was to be performed. 
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Changes in carbohydrate composition and assembly of sugars in LPS results in 
increased cell surface diversity and leads to changes in virulence. The lex2B in H 
injluenzae and its analogs in other bacteria such as H somnus (Inzana et.al., 1997), H 
pylori (Alm et.al., 1999), N. gonorrhoeae (Erwin et.al., 1996) and N. meningitis 
(Jennings et.al., 1995) appears to have an important role in phase variation of LPS or 
LOS epitopes. The presence of the lex2B gene in LPS biosynthetic loci appears highly 
conserved in these bacteria. RFLP and sequence analyses have shown that the 
appearance of lex2B in C. jejuni and C. coli is an exception rather than the rule (Yates, 
1998; Upritchard, 1997; Sanger centre, 1998). This suggests that lex2B is either a novel 
evolutionary addition to the C. jejuni and C. coli chromosome or a gene whose function 
is becoming non-essential for this genera. Furthermore the position of lex2B among LPS 
sugar transferases and the amino acid similarity between them suggests that lex2B could 
be a member of a glycosyl or galactosyl transferase super family. 
The genus Campylobacter is not well characterised genetically. Successful molecular 
methodologies used to manipulate E. coli and S. typhimurium genetics have proven 
unsuccessful for C. jejuni. Interspecies complementation of lex2B in E. coli and S. 
typhimurium is not possible as these organisms lack this gene. 
Investigation into the organisation and regulation of LPS biosynthetic genes in C. jejuni 
and construction of isogenic mutants should provide information on the role of LPS in 
C. jejuni virulence (Ketley, 1997). It may be possible to construct a live attenuated 
vaccine candidate, arising from the creation of isogenic mutants. This would be a 
mutant capable of causing an immune response in the host, yet unable to invade the host 
intestine. 
1.7.1 AIMS 
• To identify the location of the lex2B gene within C. jejuni strains 928 and 
NCTC11168. 
• To determine whether the gene, if present, is expressed. 
• To express the protein and develop a rapid test for lex2B detection. 
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• To create a null mutation to assess the role of the Lex2B protein ill LPS 
biosynthesis, and subsequent pathogenesis. 
These aims were carried out to determine if lex2B alters virulence of C. jejuni, by 
changes in LPS composition, as shown in other bacteria. By sequencing the lex2B gene 
from C. jejuni it will be shown whether the predicted Lex2B protein differs from that in 
C. coli M275, H pylori and the non-enteric bacteria H influenzae, N gonorhoeae, N 
meningitis. Sequence analysis was performed in order to assist in constructing a "null" 
mutation within the C. jejuni 928 chromosome and in prediction of possible connections 
that Lex2B has with other sugars transferases using hydrobic cluster analysis. Southern 
and dot-blot analyses were used to determj.ne the copy number of lex2B on C. jejuni 
chromosome and detection of lex2B in other C. jejuni and C. coli strains. The lex2B 
gene expression was studied using RT-PCR to detect production of mRNA. Following 
expression analysis, expression of Lex2B protein was detected using the pET vector 
system for high-level protein expression. Purified protein was used to immunogenise 
rabbits to generate a polyclonal antibody. This antibody should provide an effective tool 
for screening all Campylobacter strains for the presence of the Lex2B protein . 
. This experimental procedure should provide strong evidence for lex2B expression and 
the possible functions of lex2B C. jejuni and C. coli. 
CHAPTER II 
MATERIAL AND METHODS 
2.1 BACTERIAL STRAINS AND PLASMIDS 
The E. coli strains used in this study are listed in Table 2.1. The Campylobacter strains 
used in this study are listed in Table 2.2. Plasmids used or developed in this study are 
described in Table 2.3. 
Table 2.1. E. coli strains and plasmids used 
Escherichia coli GENOTYPE REFERENCE 
KLC4000 DH5a.; LllaeUI69(~80laeZ ~15) laeYl, reeAl Laboratory collection 
KLC4157 X705; F"Zeu-4$ RStr Rarg-35 T6RA,- Curtiss et al., 1968 
KLC4158 X711; F"Zeu-4$R LlproABl18 T3R arg-35 T6RLlgmhA strR Curtiss et al., 1968 
KLC4166 P- dem- ompTrB mB -Zon- A, (DE3) pLysS, CmR Laboratory collection 
KLC417I KLC 4166//pET IIa, CmR, ApR Laboratory collection 
KLC4216 KLC4000IlpDJ4216; gmhA+, Zex2H", ApR This study 
KLC4269 KLC415811pDJ4216; gmhA+, Zex2B+, ApR This study 
KLC4283 KLC4158I1pGEM-T; ZaeZ', ApR Laboratory collection 
KLC4370 KLC40001lpJK4370; ZaeZ+, ApR, KmR Laboratory collection 
KLC4371 KLC4000Ilpn<Jl030; Lllex2B, CmR,KmR This study 
KLC4375 KLC 40001lpDJ4375; Lllex2B, ApR,KmR This study 
KLC4376 KLC40001lpMEK180; KmR Laboratory collection 
KLC4377 KLC 4166//pJI<P030; L1lex2B, CmR,KmR This study 
Abbreviations: Ap: ampicillin, Km: kanamycin, Cm: chloramphenicol, Str: streptomycin, Tet: 
tetracycline: R= resistant, :: = insert. 
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Bacterial strains followed by a double back slash (I I) indicate that strain has been 
transformed with a plasmid. 
Table 2.2. Campylobacter strains used 
ISOLATE NAME SOURCE SPECIES 
KLC4239 HF928 MedLab South Cjejuni 
NCTCll168(1958) HFNZRM C.jejuni 
KLC4297 HFCHL Cjejuni 
KLC4303 HFCHL Cjejuni 
KLC4305 HFCHL Cjejuni 
KLC4315 HFCHL Cjejuni 
D0399V HFCHL C.jejuni 
YP502F HFCHL Cjejuni 
LG430P HFCHL Cjejuni 
MB617S HFCHL Cjejuni 
RC167B HFCHL C. coli 
ZP028D HFCHL Cjejuni 
M275 Dr. M. Konkel, Washington State University C coli 
Abbreviations: HF: human faeces, NZRM: New Zealand Reference Material, CHL: Canterbury Health 
Laboratory 
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Table 2.3. Plasmids used in this study 
PLASMID DESCRIPTION REFERENCE 
pDJ 4216 pGEM-T::gmhA+ lex2B+ LlwaaF, 4.7 kb, ApR This study 
pDJ 4269 pGEM-T::gmhA+ iJ.lex2B, 4.1 kb, ApR This study 
pll(P010 pCR2.1:: iJ.lex2B, 4.57 kb, ApR, KmR J. Klena 
pll(P021 pCR2.1::pMOMP:: Lllex2B, 4.85 kb, ApR, KmR J. lUena 
pll(P030 pET24b:: Lllex2B, 5.95 kb, KmR J. lUena 
pJK3056 pBIISK+::gmhA+ lex2B+ waaF*, 5.8 kb, ApR J. Klena 
pJK4370 pBIISK+:: 1(m200, 4.26 kb, ApR, KmR J.IUena 
pMEK180 Campy ori, 10 kb, KmR J. Klena 
pDJ4375 pJK4370:: iJ.lex2B, 4.9 kb, ApR, KmR This study 
pBluescript II SK + lacZ', ColElori, 2.96 kb, ApR Stratagene 
pGEM-T lacZ', ColEori, 3.0 kb, ApR Promega 
pET24b lacl' , flori, 5.3 kb, KmR Stratagene 
pCR2.1 lacZ', ColElori, 3.9 kb, ApR, KmR Invitrogen® 
pET11a lacN, ColElori, 5.6 kb, ApR Stratagene 
2.2 BUFFERS AND MEDIA 
Solutions and media used in this study were prepared as described ill 
Appendices 1 and 2. 
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2.3 BACTERIOLOGICAL METHODS 
2.3.1 CULTURE CONDITIONS 
C. jejuni and C. coli isolates were incubated in a water-jacketed C02 incubator (Nuaire) 
in a microaerophilic environment (10% C02), at 37°C on solid media (Campylobacter 
charcoal differentiation agar, (CCDA, Oxoid» with the addition of cefoperazone (Cp) or 
on Mueller-Hinton medium. The concentrations of antibiotics used in this study are 
listed in Table 2.4. 
All E. coli strains were incubated aerobically at 37°C in Luria Bertani broth (LB) or LB 
broth containing 1.5% agar eLBA). Overnight cultures were inoculated from a single, 
isolated colony taken from a streak plate. Antibiotics and colourimetric reagents were 
added to liquid or solid media when necessary, to maintain selection pressure or to 
identify constructs, as indicated in Table 2.4. 
Table 2.4. Antibiotics and supplements used in this study 
ANTmIOTIC/CHEMlCAL ABBREVIATION FINAL· CONCENTRATION 
Ampicillin Ap 5OIlg/rnl 
Chloramphenicol Crn 20llg/rnl 
Kanamycin Krn 3OIlg/ml 
Tetracycline Tet 151lg/ml 
Cefoperazone Cp 32 llg/mI 
5-bromo-4-chloro-3-indoyI- X-gal 4OIlg/ml ~ - D-galactopyranoside 
IsopropyI-~-D- IPTG 25 mg/ml thiogalactoside 
2.3.2 STORAGE OF STRAINS 
For day to day use Campylobacter strains were maintain on CCDA plates supplemented 
with Cpo Campylobacter isolates were passaged every 48 h to maintain culturability . 
. Long term storage of isolates was achieved by harvesting bacterial growth from CCDA 
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plates using Brain Heart Infusion broth (Gibco BRL) containing sterile glycerol (BDH) 
(fInal concentration of 20%) and sterile 6rnm glass beads (BDH) contained in Nunc 
cryotubes. Aliquots of isolates were stored at -80°C until required. 
E. coli isolates were maintained on LBA streak plates, supplemented with antibiotics as 
required, at 4°C. For long term storage strains were maintained in 20% glycerol (fInal 
concentration) at -80°C. 
2.4 DNA MANIPULATION AND CLONING TECHNIQUES 
2.4.1 PREPARATION OF TOTAL GENOMIC DNA 
Isolation of chromosomal DNA from Campylobacter spp. was performed using the 
method of Po speich and Neumann (1995). Briefly, 5ml of cold, sterile ddH20 was used 
to harvest Campylobacter growth from plates as described (see section 2.3.1). Cells 
were pelleted by centrifugation at 3700xg for 10 min at 4°C. Cell pellets were 
resuspended in 250J..1l of SET buffer (Appendix 1) containing lysozyme (fInal 
concentration Img/ml) and incubated at 37°C for 60 min. 1110 volume of 10% SDS and 
proteinase K (fmal concentration 0.5mg/ml) were added and cell suspensions incubated 
at 55°C for 2 h (or until lysis was complete), with occasional inversion. After 
completion of lysis, 1/3 volume of 5M NaCl and 1 volume of chloroform were added 
and incubated, with frequent inversion, at ambient temperature for 30 min. Mixtures 
were centrifuged (14800xg for 15 min) and aqueous phases were transferred to sterile 
tubes. An equal volume of phenol/chloroform/isoamyl alcohol (IAA) was added to cell 
extracts, mixed via inversion, centrifuged as above and extracted. Chromosomal DNA 
was precipitated by adding 2 volumes of absolute ethanol and 1110 volume of 3M 
sodium acetate. Genomic DNA was collected by centrifugation for 15 min at 17400xg, 
washed with 70% ethanol and air-dried. DNA was dissolved in lOOlll of sterile ddH20 
containing RnaseA (fmal concentration of20J..1g/ml). 
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2.4.2 PLASMID EXTRACTION 
Small scale plasmid isolations were performed usmg the lysis by alkali method 
(Sambrook et.al., 1989). Plasmid DNA to be further manipulated was purified from 
excess salts or other contaminating particles by one of two methods. The first method 
used the GeneClean III kit (Bio10l, La Jolla, CA) according to the manufacturer's 
protocol. 
The second method was used to salt precipitate plasmid DNA that was to be further 
manipulated (e.g. restriction enzyme digested, ligated, and/or to have its nucleotide 
sequence determined). This method involved addition of an equal volume of 
phenol/chloroform/isoamyl alcohol (IAA) to the resuspended DNA. The two solutions 
were thoroughly mixed and the organic and aqueous phases separated by centrifugation 
at 17400xg for 4 min. The aqueous phase was transferred to a 1.5 m1 Eppendorf tube 
and two volumes of absolute ethanol were added, mixed and incubated at ambient 
temperature for 5 min. DNA was harvested by centrifugation (17400xg, 10 min, 4°C), 
washed with 1 ml of 70% ethanol and air dried before resuspending the DNA in 100Jll 
ddH20. 
2.4.3 RESTRICTION ENDONUCLEASE DIGESTION OF DNA 
Restriction endonuclease digestions 
In general, restriction endonuclease digestion reactions were carried out in 15 J.lI 
volumes, according to the manufacturer's recommendations. Digestions were usually 
incubated at 37°C for 2-3 h unless otherwise specified. Digestions involving two 
enzymes were performed using the most suitable enzyme buffer or by addition ofNaCl. 
However when this was not possible, DNA was digested initially with one endonuclease 
using the most appropriate enzyme buffer, then salt and enzyme were removed by 
phenol/chloroform/IAA precipitation, and DNA digested with a second endonuclease 
using the most appropriate buffer. 
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Dephosphorylation of 5 I overhangs 
To prevent intramolecular (self-ligation) of vector or insert DNA, calf intestinal alkaline 
phosphatase (ClAP) was added to the restriction endonuclease digestion mixtures after 
complete digestion. ClAP removes 5' phosphate overhangs from DNA. The digestion 
mixture, 2/-Ll of lOx dephosphorylation buffer (Gibco BRL), and 1 unit of ClAP (Gibco 
BRL) were brought up to a fmal volume of20/-Ll and incubated at 37°C for 30 min. The 
reaction was terminated by addition of 5mM EDTA (PH 8.0) and incubated at 65°C for 
20 min. The reaction volume was adjusted to a total of 100/-L1 and the mixture was 
extracted once with phenol:chloroform:lAA to remove enzymes. DNA was precipitated 
by addition of 1/3 volume 3 M sodium acetate (PH 4.8) and 2 volumes of cold 100% 
ethanol. After incubation at room temperature for 5 min, the mix was centrifuged at 
l7400xg for 10 min, washed with 70% ethanol and the pellet air dried briefly before 
resuspension in 20 /-Ll dH20. 
2.4.4 AGAROSE GEL ELECTROPHORESIS OF DNA 
Gel electrophoresis 
Restriction endonuclease digested DNA fragments were separated by electrophoresis 
through agarose (0.8%-2%) using Tris-Acetate-EDTA (TAB) buffer (Appendix1). 
Reactions were mixed with 1-2 /-Ll 6xbromophenol blue gel dye (Appendix 1) befpre 
loading into agarose gels. DNA fragments were separated by exposure to an electrical 
current for one hour at 100V, in a Biorad mini sub or DNA sub cell apparatus. Gels 
were stained in water containing ethidium bromide (0.5 /-Lg/ml) for 20 min. DNA was 
visualised using a Sigma T2210 UV (302 nm) transilluminator or an Ultra-Lum KS-
3000 visualisation-documentation and analysis system (Ultra-Lum, Carson, CA). 
Elution of DNA fragments from agarose gels 
After electrophoresis and staining, digested DNA fragments were excised from agarose 
using a sterile scalpel blade and placed into sterile 1.5 m1 Eppendorf tubes. DNA was 
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extracted from agarose by using the GeneClean III (Bio 101, La Jolla, CA) or Prep-a-
Gene kits (Biorad), according to methods supplied by the manufacturers. DNA was 
resuspended in ddH20. 
2.4.5 DNA LIGATION 
DNA from various sources were ligated together using either 1 /-LI of T4 DNA ligase 
(Gibco BRL) and 4 /-LI of 5x DNA ligase buffer (Gibco BRL) in a final volume of 20 /-Ll 
or I/-LI ofT4ligase (promega) and I/-LI of lOx DNA ligase buffer in a final volume of 10 
/-Ll. Ligation mixtures were incubated at 12°C for 12-24 h. Ligation mixes were either 
kept on ice or at -20°C until use. A vector:insert ratio of 1:3 was favored for high 
intermolecular ligation and low concatamer formation. 
2.5 PLASlVIID CONSTRUCTS 
Plasmids were constructed for use in complementation analysis, as substrates for 
mutagenesis, Southern hybridisation, DNA sequence determination and protein 
expression analysis. In this section I describe the important plasmids that have been 
constructed for use in this study. 
pDJ 4216 
A 1.7 kb PCR amplicon was generated using the primers 96.01 and 94.293 with DNA 
from 928, (C. jejuni KLC4239) as template. The amplicon was cloned into the modified 
EcoRV site (overhanging poly - T's) of pGEM-T (see Table 2.3). This plasmid 
construct containes gmhA + -lex2B+ -waaF' region. 
pDJ4375 
pJKPOI0 was restriction digested with EcoRI and BglII. A 0.64 kb EcoRI fragment was 
excised from the agarose gel, prepared as above (section 2.4.4) and ligated into pJK4370 
digested with EcoRI. The resulting plasmid contained lex2B without 5' and 3' ends and 
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also a Km-resistance gene. As this plasmid would encode for a Lex2B protein deficient 
in N and C termini, this plasmid construct was used to create "null" mutation, by single 
cross homologous recombination, on C jejuni 928 chromosome. 
pJKP030 
A 0.642 kb PCR amplicon was generated using primers 99.23 and 99.25 with pDJ4216 
(C jejuni 928 DNA) as the template. Two restriction enzyme sites were created, one in 
the forward 99.23 primer (SstI) and one in the reverse primer 99.25 (XhoI). The 640 bp 
amplicon was digested with the restriction enzymes, SstI and XhoI, and ligated into the 
expression vector pET24b (see Table 2.3), also digested with the same enzymes. The 
resulting plasmid, designated pJKP030, was transformed into KLC4000, reisolated and 
digested again to verify its structure. This plasmid construct was used in expression 
analysis of Lex2B in a T7 RNA polymerase-based gene expression system. 
2.6 TECHNIQUES FOR STRAIN CONSTRUCTION 
2.6.1 CALCIUM CHLORIDE TRANSFORMATION 
E. coli strains were transformed with plasmid DNA constructs usmg one of two 
methods. The first method involved preparing cells with CaCho Competent cells were 
prepared using a variation of the Sambrook et al. (1989) method. The CaCh method is 
rapid and easy to perform. This method is summarised as follows: a culture grown 
overnight in LB broth at 37° C was diluted 1: 1 00 into 10 ml of LB broth and incubated 
with aeration at 37°C to mid-log phase (generally 2h without shaldng and Ih shalcing at 
225 rpm in a water bath). Bacterial cells were pelleted by centrifugation (10 min at 
4°C), resuspended in 0.5 volume of cold 100 mM CaCh and incubated on ice for 60 
min. Cells were pelleted by centrifugation (10 min at 4°C), resuspended in 0.08 volume 
of ice cold 100 mM CaCh and incubated on ice or 60-90 min prior to transformation. At 
this point the competent cells could be stored overnight at 4°C, or at -80°C for several 
months by addition of sterile glycerol to a final concentration of 15-20%. 
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For each experiment 100-200~1 of CaCh-competent cells was used. To these cells 0.05-
0.3~g of plasmid DNA (usually about 5~1 of plasmid DNA from the alkaline lysis 
procedure) was added and the mixture incubated on ice for 30 min. Mixtures were heat-
shocked at 42°C for 90 sec without shaking and placed immediately on ice for 2 min. 
Transformants were diluted in 800 ~l LB broth and grown at 37°C for lh to allow for 
expression of antibiotic resistance genes. Transformed cells were harvested in a tabletop 
centrifuge for 1 min and resuspended in 200~1 LB broth. Transformants were spread-
plated onto LBA supplemented with appropriate antibiotics and cultured overnight at 
37°C unless otherwise specified. Single transformants were purified and plasmid DNA 
was isolated to verify the presence of the correct construct. 
2.6.2 Campylobacter jejuni COMPETENT CELLS 
Campylobacter spp. are naturally competent for acquisition of homologous DNA, 
however for heterologous and plasmid DNA competence drops significantly. C. jejuni 
cells that have been made electrocompetent are more susceptible for transfomation with 
plasmid DNA. 
The method for malting C. jejuni competent cells (M. Konkel per. comm.) is 
summarised as follows: a C. jejuni culture was grown on Mueller-Hinton agar with 
blood (MHBA) using conditions described in section 2.3.1. Bacterial growth was 
harvested from a plate using 5 ml of Mueller-Hinton broth without blood and transfered 
into 250 ml of the same medium. Cultures were incubated in a sealable jar with a candle 
to create a microaerophilic environment. After 24h (or until reaching approximately 
Ixl07 cfulml) , cells were chilled on ice for 20 min. Bacterial cells were pelleted by 
centrifugation at 5150xg for 10 min at 4°C. The reSUlting pellet was resuspended in 
250ml of ice cold, sterile water. Cells were pelleted as before and resuspended in 125ml 
of ice cold ddlliO. Cells were harvested as above and resuspended in 5ml of ice cold 
sterile 10% glycerol. In [mal step, cells were pelleted as before, resuspended in 0.5 ml 
of ice cold sterile 10% glycerol and aliquoted into 50 ~l aliquots. Electroporation of the 
plasmid was carried out as described in section 2.6.3. After electroporation bacterial 
cells were resuspended in 200~1 of Mueller-Hinton broth and plated on MHBA without 
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antibiotic. Following 24 h incubation as described in section 2.3.1, C. jejuni growth 
from the non-selective plates were streaked onto MHBA with kanamycin (final 
concentration 200 /!g/ml). Transformants were expected within 48 h, and spontaneous 
revertants beyond this period. 
2.6.3 ELECTROPORATION 
Electroporation has been demonstrated to be a more efficient means of DNA transfer 
than CaCh transformation. Competent cells were prepared using a variation of the 
protocol supplied with the Bio-Rad Gene Pulser (Bio-Rad, Richmond, CA). An 
overnight culture was diluted 1: 1 00 into LB broth and incubated until early mid-log 
phase (typically 2 h without shaking and 1h with shaking at 37°C) and chilled on ice for 
20 min. The cells were centrifuged at 10300xg for 10 min at 4°C. The cell pellet was 
resuspended in 1 volume of deionised water (dH20) and collected as before. The pellet 
. was then resuspended in 0.5 volume dHiO and cells collected as before. The pellet was 
resuspended in 0.08 volume of cold, sterile 10% glycerol, transferred to a 1.5 ml 
Eppendorf tube and centrifuged at 10300xg for 10 min at 4°C. The cells were 
resuspended in 0.0032 volume of sterile 10% glycerol and divided into 40 /!l aliquots 
for immediate use, or stored at -80°C for several months. Electroporation was carried 
out using a Gene Pulser™CBio-Rad) with the following settings: 25/!F, 2.5kV and 
2500hms. Electrocompetent cells were mixed with 3 /!l of plasmid DNA (usually 0.05-
1.0/!g) for one min before the mix was transferred to an ice cold gene pulser cuvette 
CBio-Rad) and pulsed at the above settings, usually giving a time constant of 4.0-4.6 
msec. Immediately following the pulse, 1ml of SOC (Appendix 1) was added to the 
transformants, these were transferred to a sterile Eppendorftube and incubated at 37°C 
for 1h with aeration. Transformants were pelleted by centrifugation for 1 min at 
17400xg and resuspended using 100 /!l of fresh LB broth and spread plated onto 
selective LBA plates. 
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2.7 RNAMANIPULATION 
2.7.1 ISOLATION OF TOTAL RNA 
5 ml of cold sterile dd.H20 was used to harvest Campylobacter growth from a plate 
incubated as described (see section 2.3.1). 1 ml (~lxl09 cells) of this suspension was 
centrifuged at 5000xg for 5 min at 4°C. The resultant pellet was resuspended with 
lysozyme-containing TE buffer (fmal concentration of lysozyme- 400llg/ml) and 
incubated for 10 min at ambient temperature. RNA was isolated using the protocol 
supplied within the RNeasy Mini Kit (Qiagen). After isolation, total RNA was digested 
with DNaseI (3U/IlI) (Gibco BRL) 
2.7.2 HANDLINGRNA 
Precautions to avoid introducing RNases into the RNA sample during or after the 
isolation procedure were performed. Glassware, electrophoretic tanks and solutions used 
for RNA work were treated with 0.1 % diethyl pyrocarbonate. (DEPC). Proper 
microbiological, aseptic techniques for RNA work such as use of aerosol barrier tips and 
frequent changes of gloves were applied. Work was done in a specially adapted RNA 
cabinet constructed of P ersp ex and containing a UV lamp. 
2.7.3 RT-PCR 
Detection ofmRNA by the two step Reverse Transcription-PCR CRT-PCR) was chosen 
to study the expression of lex2B. Prior to first strand synthesis, total RNA (l-5Ilg) was 
divided into the three Eppendorf tubes (l01l1 of RNA into each tube). One tube was 
digested with 3U/lll DNase! (GibcoBRL) for 25 min at 20°C. A second tube was treated 
with 0.5 III of 10mg/mi RNaseA for 30 min at 37°C and a third sample was digested 
with a combination of these enzymes. DNaseI was inactivate by heating at 95°C for 5 
min. All buffers and enzymes were purchased from Gibco BRL. 
The fIrst step, synthesis of eDNA, was carried out in a 20111 reaction volume containing 
llli of total digested RNA. RNA was mixed with 4JlI 5x First strand buffer, 2Jll O.lM 
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DTT, and 10mM dNTP mix and incubated for 2 min at 42°c' Superscript™ II (reverse 
transcriptase) was added and samples were incubated at 42°C for 50 min. Reactions 
were stopped by incubation at 70°C for 15 min. After cDNA synthesis, additional 
digestion with RNaseA was performed on some samples to remove RNA 
complementary to eDNA. 
In a second step, 10% of the fIrst strand reaction was used for PCR. Samples were 
amplifIed using the two sets of primers: 98.21 (Forward)/ 94.375 (Reverse) as lex2B 
internal primers and 97.21 (Forward)/97.23 (Reverse) 16S rDNA primers as a positive 
control (see Table 2.5). PCR amplifIcation was initiated with a three stage programme 
consisting of 32 repeated cycles (see section 2.10). 
2.8 EXPRESSION OF lex2b IN E. coli 
A bacteriophage T7 RNA polymerase/promotor system developed by Studier and 
Moffatt (1986) was used to study expression of lex2B in E. coli. This system allows 
high levels of expression of some genes that are not expressed efficiently in other 
systems or produce a product toxic to the E. coli cells. 
2.8.1 INDUCTION OF lex2B IN pET24b CELLS GROWN IN STRAIN 
KLC4377 E. coli UNDER T7 PROMOTER CONTROL 
For induction of the lex2B encoded protein from C. jejuni 928 strain into E. coli 
KLC4377, methods recommended by the manufacturer (Stratagene) of the pET vector 
system were used. Briefly, KLC4166, KLC4171 and KLC4377 were grown from single, 
isolated colonies in 10 ml of LB medium containing Ap and Cm at 37°C for 16 h. 2 ml 
of these cultures were used to inoculate 50 ml of fresh LB broth containing selective 
antibiotics and incubated at 37°C with aeration. Cultures were grown until an OD600 of 
0.4-0.6 was reached. 1ml aliquots of each culture was removed, to serve as an 
uninduced control. IPTG was added to the remaining cultures from a 500mM stock to a 
fInal concentration of 2mM. Incubation was continued for 24h, measuring OD600 every 
30 min for 5h, with subsequental removal of 1ml aliquots. The last sampling was carried 
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out after 24h. Immediately after removing 1 ml of culture from each reading, samples 
were centrifuged at l0300xg for 5 min, the pellet was resuspended in appropriate 
volume of ddH20 and 1 volume of 2x loading buffer (Appendix II). 
In order to visualise induction of the target protein Lex2B, samples. were boiled for 5 
min and analyzed by Commassie Brilliant Blue staining of an SDS-PAGE gel (25 J-ll 
loaded sample loaded into a 15% separating polyacrylamide gel). 
2.8.2 QUANTITATION OF PROTEINS - BRADFORD METHOD 
The Bradford method is a rapid and easy method to quantitate proteins. This method 
depends on quantitification of a dye, Coomassie Brilliant Blue, binding to unknown 
proteins and comparing this binding to that of different lmown concentrations of a 
standard protein, such as bovine serum albumin (BSA).This method was used to 
quantitate the amount of proteiri present after each sampling in protein expression 
studies. Briefly, 60 ml of each sample was mixed with 3 ml of Bradford solution which 
contains Commasie Brilliant Dlue dye (protein Assey Kit, BioRad). Mixtures were 
gently inverted, vortexed and left at ambient temperature for 15 min. Samples were 
transferred into disposible cuveties (BioRad) with path length 1 cm. Concentration of 
proteins in samples at A600 was determined using Hitachi U-200 spectrophotomer. 
2.9 LlPOPOL YSACCHARIDE ANALYSIS 
2.9.1 ISOLATION OF BACTERIAL LIPOPOLYSACCHARIDE 
Bacterial lipopolysaccharide was isolated using a variation of the method described by 
Hitchcock and Brown (1983). Briefly, 5 ml of sterile ddH2.0 was added to 
Campylobaeter growth as described in section 2.3.1. All growth was scraped and 1.5 ml 
was transferred to an Eppendorf tube. Cultures were centrifuged at 17400xg for 5 min. 
Pellets were resuspended in 200J-l1 of lysis buffer (20% glycerol, 5% 2-~­
mercaptoethanol, 4.6% SDS, 0.125 M Tris-hydrochloride-buffered saline (PH 6.8), and 
0.004% bromophenol blue) and boiled for 5 min. Samples were allowed to cool for 5 
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mm before incubation at 37°C for 1h in the presence of proteinase K (final 
concentration of 0.4 Jlg/Jll). After incubation, samples were cooled on ice and briefly 
microfuged, and diluted 1:2 with 60 ml of lysis buffer without proteinase K before 
freezing at -20°C. Prior to electrophoresis, LPS samples were boiled for 5 min and 
diluted 1: lOin lysis buffer. 5 JlI of each sample was loaded into a designated lane in 
SDS-PAGE gel comprised of 4.5% stacking gel and 18% separating polyacrylamide gel. 
E. coli LPS was isolated by the same method except 0.5 ml of an overnight culture was 
used· as starting material and the composition of the lysis buffer was altered (10% 
glycerol, 1 M Tris (PH 6.8), 4% 2-~-mercaptoethanol and 0.05% bromophenol blue). 
2.9.2 LPS ELECTROPHORESIS 
LPS fragments were separated using sodium dodecyl sulfate (SDS)-tricine buffer system 
(top and bottom buffer are described in Appendix 2) described by Lesse et al. (1990). 
Polymerisation was catalysed with TEMED initiation using 10% ammonium. persulfate 
(APS). A Biorad Protean™ III gel apparatus (Biorad) was used in casting and 
electrophoresis of samples (dimensions lOx 10 with 0.75 rom spacer) with a Pharmacia 
Biotech EPS 600 power supply set at constant current (35 rnA). When electrophoresis 
was completed (Le. when the bromphenol blue dye front reached the bottom of the gel), 
the plates were separated and the SDS-PAGE gel was fixed (25% v/v isopropanol and 
7% v/v acetic acid) for 16h. 
2.9.3 SILVER STAINING OF LPS SDS-PAGE GELS 
LPS was visualised using a modification of the silver staining method of Hitchcock and 
Brown (1983). Briefly, fixed gels were oxidised in freshly made solution one (Appendix 
II) for 5 min followed by eight ddH20 washes (2x30 min, 2x20 min, 4x 10 min) in 200 
ml. The water was aspirated off and 150 ml of freshly made silver stain (Appendix 2) 
was used to stain the gel for 10 min. Silver stain was decanted and the gel was washed 
four times for 10 min in 200 ml of ddH20. The gel was developed in 200 ml of citric 
acid developer (Appendix II) for 1-20 min. Stop solution (200 ml ddH20, 10 ml 7% v/v 
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acetic acid) was added when LPS and background were highest contrast. In all steps, 
gels were agitated on an orbital shaker set at a slow speed. Gels were normally allowed 
to soalc for a minimum of one hour and photographed using a SLR camera with colour 
slide photography. 
2.10 SOUTHERN HYBRIDISATION 
2.10.1 SOUTHERN TRANSFER 
Genomic DNA was digested to completion using an excess of a restriction enzyme (e.g. 
HinD III) and separated by electrophoresis through an 1 % agarose gel in a Bio-Rad mini 
sub cell apparatus. DNA located in the gels was stained using water containing ethidium 
bromide (0.5 /-lg/ml) and photographed with Polaroid 667 film (ASA 3000). DNA was 
transferred to a 10x15 cm positively charged nylon membrane (Roche) using a 
Pharmacia LKB VacuGene XL vacuum blotting system (pharmacia) and 20xSSC for 90 
min as recommended by the manufacturer. After this period the gel was restained with 
ethidium bromide and DNA visualised using an UV transilluminator to determine the 
efficiency of transfer. The DNA was fixed to the membrane by crosslinlong for 30 sec at 
1200 KJ in an U.V.C-515 ultraviolet multilinker (Ultra-lum). Membranes were either 
probed immediately or wrapped in foil and stored at ambient temperature until required. 
2.10.2 PROBE LABELING, HYBRIDISATION AND SIGNAL DETECTION 
The non-radioactive digoxygenin-dUTP (DIG) DNA labeling and detection lot (Roche) 
was used for detection of all Southern hybridisations. Hybridisation was performed 
according to the procedure described in the instruction manual. Briefly, the membrane 
was placed in a Hybaid glass tube, prewarmed at 42°C with 10 ml of hybridisation 
buffer (DIG EasyHyb, Roche). Prehybridisation was carried out for 2 h at 42°C in 
Hybaid LTD Micro-4 HB-MCR4 oven. Prehybridisation solutions were discarded and 
replaced with 10 ml of hybridisation solution containing denatured DIG-labeled probe 
(final concentration 25ng/ml). DIG-labelled probes were denatured (10 min at lOODC) 
Chapter 11 Materials & Methods 41 
prior to addition in hybridisation buffer. Hybridisation was performed at 42°e for 16 h 
with constant rotation. 
Following hybridisation membranes were washed twice (15 min per wash) in low 
stringency wash buffer (2 x sse, 0.1 % SDS) at ambient temperature to remove 
unbound probe. Membranes were washed further (twice for 15 min) in high stringency 
buffer (0.5 x sse, 0.1 % SDS) at 68°e with constant rotation. Hybridised DNA was 
detected as described by the manufacturer. Membranes were sealed in plastic with 
approximately 1 ml of eSPD and incubated at 37°e for 15 min. Results were 
documented by photography. 
2.10.3 DOT-BLOT HYBRIDISATION 
To determine if the lex2B gene was present on chromosome of other C. jejuni and C. 
coli isolates, dot-blot analysis was performed with a portion of the lex2B gene from C. 
jejuni 928 which has been DIG-labelled (see section 2.10.2). This fragment was also 
used in Southern hybridisation experiment (section 2.10.2) To a positively charged 
membrane (Roche) chromosomal DNA was added with [mal concentration of 10 ng/!J.l. 
The DNA was UV cross-linked to the membrane and developed as described in section 
2.10.2. 
2.10.4 STRIPPING MEMBRANES FOR REPROBING 
An advantage of the DIG detection system is that both the membrane and the probe are 
reusable. After hybridisation, remaining hybridisation solution containing DIG-labelled 
probe was stored at -20oe. Before reuse the hybridisation solution containing DIG-
labelled probe was freshly denatured at 68°e for 10 min. 
Membranes were stripped by rinsing in ddH20 followed by incubation at 37°e in probe 
stripping solution (0.2 N NaOH, 0.1 % SDS) for 30 min. Membranes were rinsed in 
2xSSe before repro bing. 
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2.11 POLYMERASE CHAIN REACTION OF PLASMID AND 
GENOMIC DNA 
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Polymerase chain reaction (PCR) of DNA (genomic and plasmid) and RNA was 
performed on a Corbett Research FTS-320 Thermal Sequencer. Primers for PCR were 
purchased from Gibco BRL. Deoxynucleotides (dNTPs), buffers and enzymes were 
purchased from Roche. 
In general, approximately 100 ng/ml of DNA was used for each reaction. Each PCR 
consisted of several reagents added to a thin-walled 0.5 ml Eppendorf tube (all 
concentrations are fmal for 100 J.Ll reactions): 3 pmol/ml of each primer (forward and 
reverse), 250J.LM dNTPs (dATP, dTTP, dCTP, dGTP), 1.5mM MgCh and sterile 
ddH20. To this mix was added 10 J.LI of lOx PCR buffer, 1 III of plasmid DNA and 0.5 
J..LI of Taq DNA polymerase. Mixtures were briefly pulsed in the centrifuge to collect all 
components of the reaction. Reaction mixtures were overlaid with 100 III of sterile 
mineral oil and placed in the thermal sequencer. PCR amplification was initiated with a 
three stage programme of 32 repeated cycles. Each cycle consisted of a denaturation 
step (94°C for 1 min), an annealing step (55°C for 1 min) and an extension step (72°C 
for 1 min). The annealing temperature was based on the Tm value of the primer (Bolton 
and McCarthy equation; Sambroolc, 1989) and PCR products of 1 lcb or larger were 
given an increased extension time. A final cycle used an extension time of 5 min to 
ensure that all PCR products initiated were able to be completed. PCR products were 
incubated at 4°C until removed from under the paraffin oil and stored at -20°C. Control 
reactions containing all reagents except template, absence of one primer or Taq 
polymerase were performed with every new primer or template tested. 
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Table 2.5. PCRprimers 
PRIMER PRIMER NUCLEOTIDE SEQUENCE 
97.01 (Forward) 5' -GAA TGG CAA GAA CAT CA-3' 
SP6 (Reverse) 5'-ATTTAGGTGACACTATAG-3' 
T3 (Forward) 5' -AATTAACCCTCACTAAAGGG-3' 
T7 (Forward) 5'-TAA TAC GAC TCACTATAGGG-3' 
98.21 (Forward) 5'-AAT GAAAGT TTT TAT CAT-3' 
94.375 (Reverse) 5'-CCT TGA GTT CCT GCAAG-3' 
94.293 (Reverse) 5'-GCAATAAAACCACTA TCA-3' 
97.21 (Forward) 5' -AGA GTT TGA TGM TGG CTC AG-3' 
97.23 (Reverse) 5'-GWATTACCGCGGCKGCTG-3' 
99.23 (Forward) 5' -GAG CTC AGA GCG TTC TTT AGA TAGG-3' 
99.25(Reverse) 5' -CTC GAG TTT TCT TCC ATA TTC TAC AAT AAC AC-3' 
gmhDDV 5' -GCT CAT TTG GTA GGA CIT AG-3' 
Abbreviations: M= A or C; K= G or T; W= A or T; 





Sp6 promoter, e.g. pGEM-T 
T3 promoter, e.g. pBIISK + 




16S rDNA (E. coli) 




DNA sequencing is the determination of the deoxynucleotide order of a specific 
segment of DNA. In this study DNA sequences were deduced using the chain 
termination method. The chain termination method or "Sanger dideoxy sequencing", 
depends on the enzymatic synthesis of labeled DNA, using modified nucleotides to 
terminate elongation of newly synthesised DNA (Sanger et al. 1977). 
DNA sequencing was achieved using an ABI Prism 377 DNA sequencer and fluorescent 
dye terminator technology at Waikato University. 
CHAPTER III 
RESULTS 
3.1 FUNCTIONAL IDENTIFICATION OF 
C. jejuni 928 gmhA-lex2B-waaF GENES 
Previous analyses revealed the presence of a novel arrangement of genes involved in 
heptose synthesis within C. coli M275 (Upritchard, 1997; Yates 1998). This 
arrangement, gmhA-Iex2B-waaF, was not seen in the C. jejuni NCTC11168 sequence 
strain (genome completely sequenced- Sanger, 1998). However, C. jejuni strain 928 was 
shown to produce a PCR amplicon of 1.7 kb when primed with primers 96.01 and 
94.293 (Yates, 1998). This is a PCR amplicon equivalent in size to that seen from C. 
coli M275. In 71.4% (n=105) of C. jejuni isolates from human infections (Yates, 1998), 
including NCTC11168, these primers generate a 0.9 kb PCR amplicon. The purpose of 
this thesis was to characterise the lex2B gene and to determine if it is present in some, 
but not all, C. jejuni isolates. Thus the first objective was characterisation of the 1.7 kb 
PCR amplicon from C. jejuni 928. 
3.1.1 A PLASMID CONTAINING gnihA-Iex2B-waaF' GENES FROM 
C. jejuni 928 
In order to characterise the 1.7 kb PCR amplicon generated from C. jejuni 928, 
restriction digestion analysis was performed. Cleavage sites for the restriction enzymes 
EcoRI and PstI were observed to occur in the 1.7 kb fragment of M275. Digestion of the 
1.7 kb PCR amplicon from 928 with these enzymes showed the same restriction enzyme 
profile as C. coli M275 (data not shown). This PCR amplicon was cloned into the 
expression plasmid pGEM-T (see section 2.5) resulting in new plasmid construct, 
pDJ4216. If the cloned insert was the fragment of DNA expected to be amplified, a fully 
functional gmhA gene should be present. 
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3.1.2 gmltA CROSS-SPECIES COMPLEMENTATION 
In order to test whether pDJ4216 contained a functional gmhA gene, transformation of 
an E. coli gmhA- strain with 'pDJ4216 plasmid, was tested. Restoration of WT LPS 
would suggest the presence of gmhA activity on pDJ4216. 
For functional analysis of gmhA from C. jejuni 928, E. coli Kl2 strain KLC4158 was 
used. KLC4158 has a 35 kb IS5-mediated deletion spanning the gmhA locus resulting in 
the inability to produce the glyceromannophosphate isomerase enzyme (see Table 2.1). 
Due to this defect in heptose biosynthesis, KLC4158 produces truncated LPS and as a 
result, is supersensitive to hydrophobic antibiotics and bile salts. KLC4158 was 
transformed with pDJ4216 to determine if the 1.7 kb fragment from C. jejuni 928 could 
restore to KLC4158 the ability to grow on MacConkey bile salts rich medium and 
restore full length LPS. 
Following electroporation, a total of seven transformants were harvested and patch 
strealced onto LBA, LBA+Ap and MacConkey media together with the control strains 
KLC4157 (gmhA+) and KLC4158 (gmhA} All seven KLC4158 transformants as well 
as KLC4157 grew on MacConkey media, while strains KLC4158 and KLC4283 
(KLC4158 harbouring pGEM-T) failed to grow in this bile salts rich medium. Plasmid 
DNA was extracted from the KLC4158 transformants and restriction digested with Pst I 
and EcoRI. Resultant fragments were of a size predicted from restriction digestion of the 
PCR amplicon of 1.7 kb amplicon of C. jejuni 928 (data not shown). 
The above evidence suggested glyceromannophosphate isomerase activity from C. jejuni 
928 is present and functional as judged by restoration of heptose biosynthesis on 
pDJ4216. Following these results, nucleotide sequencing of the 1.7 kb fragment was 
performed. 
3.2 DETERMINATION OF THE DNA SEQUENCE OF 
C. jejuni lex2B 
After proving that 1.7 kb fragment was capable of restoring WT LPS in a heptoseless E. 
coli (gmhA-) strain the question was what made this fragment longer in C. jejuni 928 
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than in most other C. jejuni isolates. For that purpose DNA sequence analysis was 
conducted. The complete nucleotide sequence of 1.7 kb insert on pDJ4216 was 
determined for both DNA strands (primers T7 and 98.17; primers 98.21 and Sp6 (see 
section 2.10)). Nucleotide sequencing also oriented the gene order on the plasmid 
pDJ4216. 
Analysis of DNA sequence revealed the presence of two complete ORFs (Figure 3.1). 
The first ORF is 561 nucleotides in length and is capable of encoding a polypeptide of 
187 amino acids with a calculated molecular mass of 21 IcDa (Figure 3.1). The ORF is 
terminated by a double stop codon (TAATGA). Six bases upstream of the proposed 
ATG initiation codon is a potential Shine-Dalgarno ribosomal binding site (AGGA). 
Nucleotide sequence of this ORF was analysed using the BLAST server and Clustal V 
to determine if, once translated, any amino acid similarities exist between this ORF in 
C. jejuni 928 and the amino acid sequence from C. coli M275 and C. jejuni 
NTCT11168. Global analysis (entire sequence) of the amino acids composing the first 
C. jejuni 928 ORF revealed 94% identity and 97% similarity with GmhA of C. coli 
M275. Strong identity was also found with GmhA (98%) from C. jejuni NCTC1168 
(Figure 3.2). Based on the complementation profile and extensive amino acid 
conservation of GmhA between C. jejuni and C. coli, the first ORF of C. jejuni 928 was 
proposed to be gmhA. The 561 nucleotides composing the gmhA gene have a mol% 
eG+C) content of 35.1 % which is consistent with that reported for other C. jejuni genes 
(Nuijten, 1990) .. 
The second ORF is positioned downstream of the gmhA gene. It is 765 nuc1eotides in 
size and is transcribed in the same direction as gmhA. Inspection of the sequence 
upstream of the methionine initiation codon (within gmhA) or upstream of gmhA failed 
to reveal potential-35 and -10 consensus sequences. This would suggest the ORFs are 
transcriptionally coupled, perhaps as part of a larger operon, unlilce the situation 
reported for the gmhA in E. coli which is unlinked to other genes (Brooke, 1996). The 
second ORF was capable of encoding a polypeptide of 255 amino acids, with a 
calculated molecular mass of 30.57 lilla. The ATG start codon overlaps the 3' end of 
gmhA gene by three bases (Figure 3.1). This ORF is terminated by an ochre termination 
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codon (T AA). Seven bases upstream of the proposed methionine initiation codon is a 
potential ribosomal binding site (GAGG). The 765 nucleotides composing this ORF 
have a mol% (G+C) of25.5% which is slightly more AT-rich than that of the rest of the 
C. jejuni chromosome (Nuijten, 1990). 
10 20 30 40 50 60 
5'CAAGAGTTGAATTGATCGACTTTGAAGAAGGATTTAGTACGAGTAAGATTATAGAAAAGA 
RES 70 80 90 100 110 120 
TTAAGGATAAAAAATGATAAATTTAGTAGAAAAAGAATGGCAAGAACATCAAAAAATCAT 
MIN L V EKE W Q E H Q K I I 
gmhA • 
130 140 150 160 170 180 
TCAAGAAAGTGAAATTTTAAAAGGACAAATCGCTAAAGTAGGTGAGCTTTTATGTGAATG 
Q ESE ILK G Q I A K V GEL L C E C 
190 200 210 220 230 240 
TCTTAAAAAAGGTGGTAAAATTTTAATTTGCGGAAATGGTGGAAGTGCAGCTGATGCACA 
L K K G G K I L I C G N G GSA A D A Q 
250 260 270 280 290 300 
GCATTTTGCAGCTGAACTTAGTGGGCGTTATAAAAAAGAACGCAAGGCTTTAGCAGGTAT 
H F A A E L S G R Y K K E R K A LAG I 
310 320 330 340 350 360 
AGCACTTACAACCGATACTTCAGCGCTTAGTGCTATAGGAAATGACTATGGTTTTGAGTT 
A L T T D T SAL S A I G N D Y G F E F 
370 380 390 400 410 420 
TGTTTTTTCAAGACAAGTGGAGGCTTTAGGAAATGAAAATGATGTTTTAATCGGCATTTC 
V F S R Q v E A L G N END V L I GIS 
430 440 450 460 470 480 
AACCAGTGGAAAAAGTCCCAATGTTTTAGAAGCTTTTAAAAAAGCAAAAGAACTTAATAT 
T S G K S P N V LEA F K K A K E L N M 
HinDID 
490 500 510 520 530 540 
GCTTTGTTTAGGGTTTAGTGGAAAGGGCGGTGGAATGATGAATAAGCTTTGTGATCATAA 
L C L G F S G K G G G M M N K LCD H N 
EcoRI 
550 560 570 580 590 600 
TCTTGTTGTGCCAAGCGATGATACGGCTAGAATTCAAGAAATGCACATTTTAATCATACA 
L V V P S DDT A R I Q E M H I L I I H 
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610 620 RBS 630 640 650 660 
CACACTTTGTCAGATCATCGATGAGGGTTTTTAATGAAAGTTTTTATCATAAATTTAGAG 
M K V F I I N L E 
T L C Q I IDE G F * * 
lex2B 
670 680 690 700 HmDIn 710 720 
CGTTCTTTAGATAGGAAAGAGCATATGAAAAAACAAATTCAAAAGCTTTTTGAAAAAAAT 
R S L D R K E H M K K Q I Q K L F E K N 
730 740 750 760 770 780 
CCTAGTTTAAAAAATAAATTAGAATTTATTTTCTTTAAAGCTATTGATGCTAAAAATAAA 
P S L K N K L E F IFF K A I D A K N K 
790 800 810 820 830 840 
GAACATTTGGAATTTAAAGATCATTTTCCTTGGTGGGGTTCTTGGGTTTTGGGTAGAGAG 
E H L E F K D H F P W W G S W V L G R E 
HinDIn 
850 860 870 880 890 900 
CTTTCTGATGGAGAGAAAGCTTGTTTTGCTAGTCATTATAAACTTTGGCAAGAATGTGTG 
LSD G E K A C F ASH Y K L W Q E C V 
HmDrn 910 920 930 940 950 960 
AAGCTTGATGAGCCTATAATCATCCTAGAGGATGATGTGGAATTTAGTGATGAATTTTTA 
K L D E P I I I LED D V E F S D E F L 
970 980 990 1000 1010 1020 
AATAATGGAGTAGAATATATAGATGAGCTATTAAAGAGCAAATATGAATATATAAGACTT 
N N G V E Y IDE L L K SKY E Y I R L 
1030 1040 1050 1060 1070 1080 
TGTTATTTATTTGATAAAAGATTGTATTTTTTGAGCGAGAGTGGATATTATTTAAGTATT 
C Y L F D K R L Y F L S E S G Y Y LSI 
Pst} 
1090 1100 1110 1120 1130 1140 
GAAAAACTTGCTGGAACTCAAGGCTATGTACTGCAAGTAAGTGCTGCAGTGAAATTTCTT 
E K LAG T Q G Y V L Q v S A A V K F L 
1150 1160 1170 1180 1190 1200 
AAATATGCTAAAAATTGGATCTATGCTGTAGATGATTATATGGATATGTTTTATAAACAT 
K YAK N W I Y A V D D Y M D M F Y K H 
1210 1220 1230 1240 1250 1260 
AATGTGTTAAATATAGTTAAAAAGCCTTTATTTCTTAAGCAAGCAAATTTTTCAAGTGTT 
N V L N I V K K P L F L K Q A N F S S v 
1270 1280 1290 1300 1310 1320 
AT TGTAGAATATGGAAGAAAATTTTCAATAAAATTAATATTATATAAAAAAATTGCTAGA 
I V E Y G R K F S I K L I L Y K K I A R 
1330 1340 1350 1360 1370 1380 
GAAATTTTTAGATTTTATTCAAGTATTTTAAGGTTACTATTTATTATATATATAAAAAAT 
ElF R F Y S S I L R L L F I I Y I K N 
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HinDill 
1390 1400 1410 1420 1430 1440 
CAATTAAAGCTTAAGTAAATTCCTAGCTTCTTCTATAACCCTTTGAGGCTTTAAATCTTT 
Q L K L K * 
* RAE E I V R Q P K L D· K M C K H H 
1450 1460 1470 1480 1490 1500 
CATGCATTTGTGGTGTTTTAAAGGGCAGGTTTTTTGCATACAAGGCATACAAGCTAGAAC 
K L P C T K Q M C P M CAL V L H V W R 
1510 1520 1530 1540 1550 1560 
TAAATGCACCCATCTTGCATTTTGATTTTGCCAAGGTGAAGTTTGAGTAAATTTCGTAGG 
A N Q N Q W PST Q T F K T P G F I V V 
1570 1580 . 1590 1600 1610 1620 
GCCAAAAATAACTACGGTTTTTACCTTATAAACTGCACTTAGGTGCATAGGACCACTGTC 
T K V K Y V A S L H M P G S D N T L F S 
1630 
GTTTGTGAGAAAAGATCGC 3' 
R K S L L S 
... waaF' 
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Figure 3.1. Nucleotide sequence and deduced amino acid sequence of C. jejuni 928 DNA spanning 
primers 96.01 to 94-293 (numbered from the 5' end). The translated nucleotide sequence shows two 
complete open reading frames (ORFs) that most likely are gmhA and lex2B and the partial ORF is waaF 
transcribed in an opposing direction. The bold, underlined sequence (AGGA) and (GAG G) denote 
possible ribosomal binding sites (RBS). Start and stop codons are indicated in bold for the respective 
ORFs. Restriction endonuclease sites PstI, EcoRI Hind ill are indicated in bold and labelled accordingly. 
The T7 promoter is at 5' end of the fragment while the Sp6 promoter is at 3' end.The deduced amino acid 
sequence reported in single letter code is dermed: A (alanine); R (arginine); N (asparagine); D (aspartate); 
C (cysteine); Q (glutamine); E (glutamate); G (glycine); H (histidine); I (isoleucine); L (leucine); K 
(lysine); M (methionine); F (phenylalanine); P (proline); S (serine); T (threonine); W (tryptophan); Y 
(tyrosine); V (valine). 
BLAST analysis (tblastx) of the second ORF contained within pDJ4216 revealed three 
regions in the translated polypeptide that exhibited approximately 50% identity and 70% 
similarity to the Lex2B protein from H injluenzae. The first region, encompassing 
amino acids 6 to 32, has 55% identity and 74% similarity to H injluenzae Lex2B. The 
second region, amino acids 67 to 109, revealed 53% identity and 76% similarity and the 
third region (amino acids 155 t0193) displayed 46% identity and 56% similarity to the 
H injluenzae Lex2B (Figure 3.3, Appendix Ill). This data suggests that some domains 
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within the amino acid sequences between the two species are conserved. The putative C. 
jejuni 928 Lex2B also shows extensive conservation with glycosyl transferases such as 
the LobI from H somnus (average 42% identity), Lex2B (H pylori), LgtB (N 
gonorrhoeae) and LgtE (N meningitidis) (Figure 3.3, Appendix III). Interestingly C. 
jejuni 928 Lex2B shows only 72% identity and 80% similarity, at the amino acid level, 
to Lex2B from C. coli M275 (Figure 3.4 B). However at the nucleotide sequence level 
there is 84% identity (Figure 3.4 A). 
Analysis of the remaining nucleotide sequence revealed a partial ORF (of 241 
nucleotides) transcribed in an opposing direction, capable of encoding 84 amino acids 
(Figure 3.1). The ORF ends with an ochre (TAA) termination codon overlapping the 
stop codon of the lex2B. As expected, the presence of an initiation codon was not 
observed with the sequence primer 94-293 occuring within the coding region of the 
waaF gene C. jejuni NCTCIII68. BLAST analysis of the partial ORF contained within 
pDJ42I6 after the lex2B termination codon revealed a 40 amino acid segment that 
exhibited 31% identity and 54% similarity to WaaF proteins from E. coli and S. 
typhimurium. A 57 amino acid region showed 41 % identity and 64% similarity to the 
WaaF protein of H pyiori (Appendix III). 
Translation of deduced sequences for the two complete ORFs and one partial 
ORF suggest that the order of genes on the 1.7 kb C. jejuni 928 PCR amplicon as 
gmhA-lex2B-waaF. Clearly C. jejuni 928 contained a gene which had a high degree of 
identity to lex2B from numerous bacterial species. What is unclear, however, was 
whether this gene also existed in other C. jejuni strains, but in a heterologous location. 
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Cjej928 181 IIDEGF 
CcolM275 181 IVDESF 
Cjej1958 181 IIDESF 
Figure 3.2. Alignment of C. jejuni 928 (Cjej928), C. coli M275 (CcoIM275) and C. jejuni NCTCl168 
(Cjej1958) nucleotide (gmhA) and amino acid (GmhA) sequences). 
Panel A. Nucleotide sequence alignment. 
Panel B. Amino acid sequence alignment 
Gaps, indicated by dashes, were introduced to obtain maximal alignment; "*,, indicates identical 
nucleotides; 
-
indicates identical amino acids 
-
indicates related amino acids 
-
indicates different amino acids 
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Figure 3.3. Amino acid sequence alignment ofLex2B homologous proteins from different bacterial 
sources: C.jejuni 928 (lex2B92 8); H. injluenzae type b (lex2BHi) accession no. U05670 ; H. somnus 
(loblHs) accession no. U94833; H. pylori (lex2BHp) accession no. AE000594; N. gonorrhoeae 
(lgtBNg) accession no. U13554 andN. meningitidis (lgtENrn) accession no. U25839. Amino acid 
sequences identified with BLAST by similarity to the deduced amino acid sequence from the C. jejuni 
lex2B homolog, were aligned (entire length) using Clustal V and displayed using Boxshade. Gaps, 
indicated by dashes, were introduced to obtain maximal alignment. 
-
indicates identical amino acids 
-
indicates related amino acids 
-






































***** * ******** *********************** ****** * 
TAT GAAAAAACAAATTCAAAAGCTTTTTGAAAAAAATCCTAGTT TAAAAA 
CATGCAAAGGCAAAATCAAAAACTTTTTGAAAAGAACCCTAGTCTAAAAA 
*** *** **** ****** *********** ** ****** ****** 
ATAAATTAGAATTTATTTTCTTTAAAGCTATTGATGCTAAAAATAAAGAA 
ATAAGCTAGAATTTATTTTCTTTAAAGCCGTTGATGCTAAAAATAAAGAA 
**** ********************** ******************** 
CATTTGGAATTTAAAGATCATTTTCCTTGGTGGGGTTCTTGGGTTTTGGG 
TATTTAGAATTTAAACAACATTTTCCTTGGTGGGCTTCTTGGGTTTTAGG 
**** ********* * **************** ************ ** 
TAGAGAGCTTTCTGATGGAGAGAAAGCTTGTTTTGCTAGTCATTATAAAC 
TAGAGAGCTTAGTGATGGAGAAAAGGCTTGTTTTGCGAGTCATTATAAAC 
********** ********* ** *********** ************* 
TTTGGCAAGAATGTGTGAAGCTTGATGAGCCTATAATCATCCTAGAGGAT 
TTTGGCAAGAATGTATAAAACTTGATAAACCTATAATCATCCTAGAAGAT 
************** * ** ****** * ***************** *** 
GATGTGGAATTTAGTGATGAATTTTTAAATAATGGAGTAGAATATATAGA 
GATGTTGAATTTAGTGATGAATTTTTAAATAATGGGGAAGAATACATAGA 
***** ***************************** * ****** ***** 
TGAGCTATTAAAGAGCAAATATGAATATATAAGACTTTGTTATTTATTTG 
AGAATTATCAAAGAGTGAGTATGAATATGTAAGATTTTGTTATTTGTTTG 
** *** ****** * ********* ***** ********** **** 
ATAAAAGATTGTATTTTTTGAGCGAGAGTGGATATTATTTAAGTATTGAA 
ATAAGAAATTTTATCCTTTAAATGAAAATT-ATATT--CTAAGTTTTGAA 
**** * *** *** *** * ** * * ***** ***** ***** 
AAACTTGCTGGAACTCAAGGCTATGTACTGCAAGTAAGTGCTGCAGTGAA 
AAACTTGCAGGAACTCAAGGTTACGTATTAAAACCTAGTGCTGCAAACAA 
******** *********** ** *** * ** ********* ** 
ATTTCTTAAATATGCTAAAAATTGGATCTATGCT-GTAGATGATTATATG 
ATTTATATCAAAGGC-AAAATTTATTTATACACCCGTGGATGATTATATG 
**** * * * ** **** ** * ** * ** ************ 
GATATGTTTTATAAACATAATGTGTTAAATATAGTTAAAAAGCCTTTATT 
GATATGTTTTATAAACATAAGGTATTAAATATCGTAAAAAAACCTTTATT 
******************** ** ******** ** ***** ******** 
TCTTAAGCA-AGCA--AATTTTTCAAGTGTTATTGTAGAATATGGAAGAA 
ATTAAAACATAATTGTAAATTAGAAAGCGAAATTTCTAATCTTGGACGTA 
* ** ** * ** ** *** * *** * **** * * 
AATTTTCAATAAAATTAATATTATATAAAAAAATTGCTAGAGAAATTTTT 
CAAAT--AAAAAACTTAAAATT-CATAGAAAAATTGTAAGAGAATTTTTT 
* * ** *** **** *** *** ******** ****** ***** 
AGATTTTATTCAAGTATTTTAAGGTTACTATTTATTATATATATAAAA-A 
AGACTTTATAGAGATATTTCAAGATTGCTCTATGTTTTTTATATTAAGTA 
*** ***** * ***** *** ** ** * * ** * ***** ** * 
ATCAATTAAAGCTTAAGTAA 
AAAAATTAAATCTTAA----





















Cjej928 239 LRLLFIIYIKNQLKLK 
CcolM275 238 SRLLYVFYIK------
Figure 3.4. Alignment of C. jejuni 928 (Cj ej 928) and C. coli M275 (CcolM27 5) nucleotide (/ex2B) 
and amino acids (Lex2B) sequence. 
Panel A. Nucleotide sequence alignment. 
Panel B. Amino acid sequence alignment 
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Gaps, indicated by dashes, were introduced to obtain maximal alignment and may also indicate regions of 
unobtained sequence. "*,, indicates identical nucleotides; 
-
indicates identical amino acids 
-
indicates related amino acids 
-
indicates different amino acids 
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3.2.1 HYDROPHOBIC CLUSTER ANALYSIS (RCA) 
Hydrophobic cluster analysis (HCA) was chosen as a method to search for secondary 
structural motifs within the Lex2B protein of C. jejuni 928 and for comparison of tins 
protein with some well established glycosyl transferases such as LgtB from N 
gonorrhoeae. Tills method relies upon a two-dimensional (2D) representation of protein 
sequence (Gaboriaud, 1987). HCA is not based primarily on the maximization of the 
amino acid identity, but rather on the detection and comparison of the structural 
segments constituting the hydrophobic core of globular protein domains, with or 
without trans-membrane regions (Lemesle-Varloot, 1990). Between hydrophobic 
clusters are loops, willch are characterized by a high content of strong hydropilllic 
amino acids (DENQHKR) as well as in proline, glycine, serine and threonine. 
A Blast search of the deduced C. jejuni 928 Lex2B protein sequence identified 
similarity to a variety of lmown and putative ~-glycosyl transferases (Figure 3.3). 
Recently Heimichset al. (Heinrichs, 1998), characterised the WaaX protein from E. coli 
R4 as a galactosyl transferase involved in the attachment of a side branch ~-linked Gal 
to Glc II in outer domain of the core OS. Blast analysis did not reveal any similarity 
between tIlls protein and Lex2B from C. jejuni 928. However, tIlls protein was included 
in the HCA analyses since WaaX showed 2D similarity with LgtB and LgtE galactosyl 
transferases from N gonorrhoeae and N meningitidis. These two galactosyl transferases 
showed ~ 35% identity in ID alignments with the Lex2B protein from C. jejuni 928. 
Results obtained from HCA plots (Figure 3.5) highlighted similarity between Lex2B 
and LgtB and LgtE, but also with the unrelated protein WaaX. Similarity is evident 
within the N-terminal 110 amino acids. In particular, two conserved Arg residues in the 
N-terminus, a Phe-X-Phe-Phe motif 30-40 amino acids from N-terminus, and a Glu-
Asp-Asp motif located 90-110 amino acids from N-terminus, were identified as 
consensus sequence features of the galactosyl transferase family. A representive of this 
family, LgtB, catalyzes the formation of ~-D-Gal-(1-4)-a-D-GlcNAc linkage in the the 
synthesis of LOS inN meningitidis. HCA plots of Lex2B, LgtB and WaaX indicate that 
the conserved sequence features of the proteins exist in similar structural regions, 
particulary in their potential catalytic residues presented with ASp30-40, Glu_Asp_Asp90-1I0 
and their occurrence in flexible loop structures. 
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Figure 3.5. Alignments of RCA plots of Lex2B, LgtB and WaaX. Plots were made using the RCA-Plot 
program (Doriane Informatique, Le Chesnay, France). The protein sequence is written on a duplicated (X.-
helical net, and clusters of hydrophobic amino acids are circled. A comprehensive description of the 
application of the program can be found in recent review (Callebaut, 1997). Association of colours and 
signs with amino acids are described in Table 3.1. 
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Table 3.1. Classification of amino acids for HCA * (one letter code) 
Hydrophobic Strong: VILF (green); Medium: WMY (green); Mimetic: AC (black) 
Hydrophilic DENQ (red); HKR (blue) 
Special P (-,)(red); G ( • ) (black); T ( ) (black); S ( .,f. ) (black) 
*For the programs that produce color plots, the color codes are indicated in parentheses 
3.3 SOUTHERN HYBRIDISATION ANALYSIS 
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Southern hybridisation of genomic DNA from C. jejuni strain 928 and C. jejuni 
NCTC11168 were performed to confIrm that DNA rearrangement had not occurred 
during the constructionof pDJ4216, to determine the copy number of lex2B on the C. 
jejuni 928 chromosome and also to confIrm the absence of lex2B on the NCTC11168 
. chromosome. A 0.477 kb PCR amplicon generated from C. jejuni 928 DNA using the 
primers 98.21 and 94.375 (see Table 2.5) was used to construct an internal probe to 
lex2B (Figure 3.6). To confIrm that transfer of C. jejuni NCTC11168 DNA had 
occurred, the membrane was stripped and rehybridised with an internal probe for the 
16S rDNA gene. The second probe was a ~0.5 kb PCR amplicon generated from C. 
jejuni NCTC11168 DNA using the primers 97.21 and 97.23 (see Table 2.5). C. jejuni 
928 and C. jejuni NCTC11168 chromosomal DNA were restriction endonuclease 
digested using Pst I, HinD III and Nde I for C. jejuni 928 and Pst I for C. jejuni 
NCTC11168. Fragments were resolved by agarose gel electrophoresis (see section 2.9). 
The lex2B internal probe was observed to hybridise to a Pst I fragment of approximately 
4.8 kb and to HinD III fragments of ~0.46 kb, 0.18 kb and 0.15 kb (Figure 3.7). From 
nucleotide sequence data one more HinD III fragment (42 bp in size) should have 
hybridised with the probe. A band of this size has not been observed to hybridise with 
the probe and there is a strong probability that the fragment did not transfer onto the 
membrane due to small size of this fragment. The Southern profile is consistent with the 
physical map of C. jejuni 928 lex2B (Figure 3.5). Hybridisation of the lex2B probe to C. 
jejuni NCTC11168 DNA fragments was not observed. This result is consistent with the 
reported absence of lex2B on the C. jejuni NCTC11168 chromosome (Upritchard, 1997; 
Chapter III Results 59 
Sanger, 1998). Hybridisation to a single large Pst I fragment at least as large as the 1.1 
kb was predicted, since one Pst I site exists (within lex2B) on the entire insert in 
pDI4216 (Figure 3.6) and the probe binds upstream of the Pst I site. Frequent 
occurrence of HinD III fragments (restriction sequence AAGCTT) is due to low mol% 
(G+C) of lex2B. Restriction endonuclease HinD III was chosen because other restriction 
enzymes (e.g. Nde I) do not digest C. jejuni 928 DNA into small fragments. One 
probable reason for incomplete digestion by Nde I is that this restriction enzyme 
requires very pure DNA. 
Hybridisation with the 16S rDNA probe showed expected results. Hybridisation of the 
probe to both C. jejuni strains DNA resulted in detection of several bands. Multiple 
hybridised fragments are expected because the 16S rDNA is present in several copies on 
the C. jejuni chromosome. 
Collectively, Southern hybridisation indicates lex2B is present on the C. jejuni 928 
chromosome as a single copy and rearrangements of nucleotide sequence had not 
occurred during the cloning procedure. Absence of. hybridisation to the C. jejuni 
NCTC11168 genomic DNA with a lex2B probe strongly suggests that lex2B does not 
exist within this strain. 
Although strain 928 contained what appeared to be a novel gene (relative to the 
sequenced strain), it remained unclear whether this gene was functional or a non-
transcribed artifact. RT -PCR of extracted RNA, using primers specific for lex2B, was 




















Figure 3.6. Physical map showing the peR amplicon generated from C. jejuni 928 using 
single stranded oligodeoxynucleotide primers 96.01 and 94.293. Purple solid lanes indicate 
the ends of the pGEM-T vector sequence. Grey solid lines indicate the insert sequence. The 
physical map shows gene designations, coding regions and direction of transcription 
(arrows) and relevant restriction sites. Black arrows beneath the restriction map indicate 
nucleotide sequence generated from pDJ4216 with primers T7, Sp6, 98.21, 98.17, 94.375, 
99.23 and 99.25. The size and annealing position in pDJ4216 of the lex2B southern probe 
(constructed using primers 98-21194-375) is indicated. Map size is indicated by a scale bar, 
in kilobases, to the right. 
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Figure 3.7. Southern hybridisation analysis of genomic DNA from C. jejuni strains 928 and 
NCTCII168. The DNA was restriction digested with PstI (lanes 1 and 4 ), HinDIII (lane 2) and NdeI 
(lane 3), separated by agarose gel electrophoresis, transferred to a nylon membrane and probed with a 
0.48 kb DIG labelled PCR amplicon internal to the /ex2B gene (panel A). Afterwards, the membrane was 
stripped and reprobed with 0.5 kb DIG labelled PCR amplicon internal for 16S rRNA gene (panel B). 
Lanes: 1-3) C. jejuni 928; 4) C. jejuni NCTC11168. 
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3.4 DETECTION OF lex2B mRNA BY RT-PCR 
Detection ofmRNA by reverse transcription-PCR (RT-PCR) was used to monitor lex2B 
gene expression. The method combines two sequential enzymatic steps: the syntheses of 
DNA (cDNA) from the RNA template by reverse transcriptase (RT) followed by 
conventional PCR using a heat-stable DNA polymerase (Taq polymerase). The 
extremely high sensitivity of RT-PCR enables detection of rare mRNA, mRNA 
produced in small quantities or in small numbers of cells (Siebert, 1993). 
Total RNA was isolated from C. jejuni 928 and C. jejuni NCTCll168 (see section 2.7) 
and digested with DNase!. Untreated samples and DNaseI treated total RNA were 
subjected to an electrical current through 1 % agarose gel, and subsequently stained with 
ethidium bromide (see section 2.4.4) to visualise (Figure 3.8). Results show that while 
untreated RNA is contaminated with chromosomal DNA, DNaseI treated RNA removes 
this contamination. 
To investigate specific lex2B mRNA production, RT-PCR was performed on total RNA, 
. isolated from either C. jejuni strains 928 and NCTCl1168, treated with DNase!. 
Because even minuscule amounts of contaminating DNA «1%) can produce a false-
positive amplification signal in RT-PCR, total RNA was, prior to synthesis of cDNA, 
aliquoted in three tubes and treated with either RNaseA, DNaseI or DNaseIJRNaseA. 
These enzyme reaction mixtures included all reagents for cDNA synthesis (see section 
2.7) except reverse transcriptase to avoid contamination with possible DNA in these 
reagents. After synthesis of eDNA, PCR was performed with internal primers for the 
lex2B RNA (98-21 and 94-375) (see Table 2.5). PCR amplification of chromosomal C. 
jejuni 928 DNA was also included as a positive control, along with a control for PCR 
reagents and primers (Figure 3.9). To confirm that absence of the amplification signal in 
DNase! treated RNA samples from C. jejuni NCTC11168 was not due to an absence of 
total RNA, PCR was carried out with primers for 16S rDNA (97.21and 97.23- see Table 
2.5) (Figure 3.10). 
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Figure 3.9 shows the results of the RT-PCR with lex2B internal primers. Amplification 
of a 480 bp fragment (lane 2) was consistent with the expectation that lex2B was 
transcribed in C. jejuni 928. The size of the fragment and restriction endonuclease 
digestion profile generated with StyI (data not shown) were consistent with the predicted 
size of a PCR fragment estimated from the physical map of lex2B from C. jejuni 928. 
The absence of a signal from samples treated with RNaseA (lane 3) and DNaseIIRnaseA 
(lane 4) verified that amplification of the sample treated only with DNase! is due to 
mRNA from lex2B. The lack of a PCR amplicon from C. jejuni NCTC 11168 RNA with 
lex2B internal primers (lane 5) was predicted because NCTC11168 had not shown 
presence of lex2B on its chromosome (by PCR and Southern). 
A control experiment with 16S rDNA primers strongly suggests that the C. jejuni 
NCTC11168 lack of amplifi?ation with lex2B primers was not due to a lack of RNA but 
absence of lex2B mRNA in NCTC11168 (Figure 3.10). 
To investigate the speculation that the gmhA and the lex2B are transcribed for the same 
promoter, RT-PCR was conducted on C. jejuni 928 RNA treated with DNaseI using 
primers 97.01 (within gmhA), gmhDDV (gmhD) and 94.375 (within lex2B) (see Table 
2.5). Preliminary results suggest that lex2B is not transcriptionaly coupled with 
upstream genes (data not shown). However these results may be incorrect since 
expected amplicon of 3.0 kb, if genes are transcribed from the same promoter, is hard to 
obtain due to short half-life of mRNA. Also with PCR conditions used in this study it is 
unlikely a long fragment would be generated. Unfortunately time constraints prevented 
futher characterisation of the promoter of lex2B. 
In general, RT-PCR had shown that lex2B in C. jejuni 928 is likely to be functional and 
confirmed previous results (DNA sequencing and Southern hybridisation) that 
information for Lex2B synthesis does not exist in C. jejuni NCTC11168. Investigation 
of a transcriptional connection of lex2B with upsteam genes (gmhA, gmhBIC and gmhD) 
suggests that lex2B is not transcribed from the same promoter as these genes, although 
more work must be performed because to obtain large PCR amplicons (which would be 
the case if lex2B is transcribed with gmhA and upstream genes) alternate PCR protocols 
should be trialled. 
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Figure 3.8. Total RNA from C. jejuni isolates 928 and NCTCl1168. Lanes: 1) 1 kb ladder; 2) 
NCTC11168 RNA; 3) 928 RNA; 4) blank; 5) NCTC11168 DNaseI treated RNA; 6) 928 DNaseI treated 
RNA. Samples were subjected to an electrical current through 0.8% agarose gel and visualised using 
ethidium bromide staining and UV light (see section 2.4.4). 
0.5 kb 
Figure 3.9. RT-PCR of C. jejuni 928 mRNA and C. jejuni NCTC11168 mRNA with lex2B internal 
primers. Lanes: 1) and 10) 1 kb plus ladder; 2) 928 RNA treated with DNAseI; 3) 928 RNA treated with 
RNaseA; 4) 928 RNA treated with DNaseI/RNaseA; 5) NCTC11168 RNA treated with DNaseI; 6) 
NCTCI1168 RNA treated with RNaseA; 7) NCTC11168 RNA treated with DNaseI/RNaseA; 8) 
chromosomal DNA PCR; 9) negative control. 
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0.5 kb 
Figure 3.10. RT -PCR of C. jejuni 928 mRNA and C. jejuni NCTC11168 mRNA with 168 rDNA internal 
primers. Lanes: 1) and 10) 1 kb plus ladder; 2) 928 RNA treated with DNAseI; 3) 928 RNA treated with 
RNaseA; 4) 928 RNA treated with DNaseIlRNaseA; 5) NCTC11168 RNA treated with DNase!; 6) 
NCTC11168 RNA treated with RNaseA; 7) NCTCl1168 RNA treated with DNaseI/RNaseA; 8) 
chromosomal DNA PCR; 9) negative control. 
All previous results suggested that lex2B, located between gmhA and waaF and present 
in single copy on the C. jejuni 928 possess information for synthesis of the putative 
Lex2B protein. The next step was to begin a functional study of the lex2B encoded 
protein. For that propose attempts to create a "null" mutant of lex2B on the C. jejuni 
928 chromosome were made. 
3.5 ALLELIC EXCHANGE OF lex2B C. jejuni 928 
DNA sequence analysis showed that lex2B is physically connected to other genes 
involved in biosynthesis and assembly of the LPS core. Absence of a promoter sequence 
upstream of lex2B and gmhA suggested that transcription of these genes could be from 
the same promoter, located upstream of the gmhA gene. However, to determine the 
function of the Lex2B, it was necessary to create a C. jejuni 928 lex2B null mutant. 
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Comparison of LPS chemical structures (using mass spectroscopy) from lex2B+ and 
lex2B" strains would provide infonnation regarding the lex2B protein product. 
3.5.1 CONSTRUCTION OF A SUICIDE PLASMID CONTAINING L11ex2B 
The overall objective of this section was to determine if lex2B is in fact a glycosyl 
transferase. In order to achieve this, allelic exchange of lex2B from C. jejuni 928 with a 
plasmid allele, by single cross, homologous recombination was attempted. Plasmid 
pDJ4375 (Figure 3.11) was constructed such that an allele of lex2B lacking both 5' and 
3' ends was located on the suicide plasmid pBIISK +. Additionally this plasmid was 
marked with a kanamycin resistance cassette specific for expression in C. jejuni 
(Konkel, 1999). As ColEl-based plasmids such as pBIISK + cannot replicate in C. jejuni, 
kanamycin resistance can only be achieved if recombination onto the chromosome 
occurs. E. coli KLC4000 was transfonned with the resulting plasmid, pDJ4375, and 
transfonnants were selected for kanamycin and ampicillin resistance. From 31 colonies 
showing resistance to these antibiotics, 16 were selected for verification of the presence 
ofpDJ4375. Plasmids were reisolated and inserts were amplified by PCR using primers 
T7 and T3 (see Table 2.4). Only one transformant of the 16 produced the predicted 
amplicon of 2.1 kb (containing Alex2B and the Km cassette) (data not shown). The 
plasmid that generated this amplicon was restriction digested with Apa I and Pst I to 
verify its size and structure (Figure 3.l2). An ~5 kb fragment obtained from Apa I 
restriction digestion was expected since only one Apa I site is present in pDJ4375 
(within the multiple cloning site of pBIISK+). The size of observed fragment was 
consistent with physical map of pDJ4375 (Figure 3.11). To verify the insert and to 
determine the orientation of Alex2B in pDJ4375, the plasmid was digested with Pst I 
(Figure 3.12). Lengths of the fragments following Pst I digestion were also consistent 
with the pDJ4375 map. Once the structure ofpDJ4375 was confIrmed, this plasmid was 
used to transform electro competent C. jejuni 928 cells. 
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3.5.2 DETECTION OF A C. jejuni 928 [ex2B MDT ANT 
Once inside C. jejuni 928, pDJ4375 must be recombined onto the chromosome if 
kanamycin resistance is to be conferred (Figure 3.13). No kanamycin-resistant 
transformants of C. jejuni 928 were recovered after using the method described in 
section 2.6.2 despite alteration of plasmid and kanamycin concentrations. 
One explanation for these results is the poor transformation ability of Campylabaeter. It 
is lmown that transformation of Campylabaeter species by plasmid DNA or 
heterologous DNA happens at an extremely low frequency (Wang and Taylor, 1990). 
This frequency is low when either using electroporation (Miller et al., 1988) or natural 
transformation as the method (Wang and Taylor, 1990). Time constraints prohibited 
continuation of these experiments for the thesis, however these experiments are still in 
progress with attempts to alter the protocol for preparing C. jejuni competent cells. 
An alternative experiment was to insert a fully functional lex2B into a shuttle vector 
(pMEK180, see Table 2.4) and transform strain C. jejuni NCTC11168. Previous 
analyses suggested that this strain does not have information for synthesis of Lex2B 
protein. If that is the case C. jejuni NCTC11168 with an added copy of lex2B should 
alter the composition of LPS, detectable by mass spectrometry. SDS-PAGE analysis of 
LPS isolated from C. jejuni strains 928 and NCTC11168 showed that the LPS molecular 
mass differs between these two strains (data not shown). LPS from 928 has higher 
molecular mass than LPS isolated from NCTC11168, suggesting that 928 has at least 
one additional sugar in LPS. Serotyping, based on the Penner method (LPS used as 
heat-stable antigen) confIrmed that differences between the LPS of these strains exists. 
C. jejuni 928 was identified as HS 1 and C. jejuni NCTC11168 as HS2 serotype. The 
chemical structures of the LPS OS core from these serotypes revealed that GalNAc was 
present in HS 1 as the last modified sugar in the nascent hexose chain, whereas in HS2 
serotypes this sugar is missing from the OS core region. Presence of this sugar in HS 1 is 
the only difference in chemical structure of core OS between serotypes HSI and HS2. 
This difference suggests that the LPS from NCTCl1168 containing a lex2B copy could 
change from HS2 to HS 1 and show LPS of the same molecular mass as LPS from 928. 
To date the construction of shuttle vector containing the lex2B gene under a constitutive 











Figure 3.11. The restriction map ofpDJ4375. pDJ4375 is estimated to be 4.9 kb, showing the orientation 
(solid black arrow) of the C. jejuni 928 truncated lex2B insert in pJK4370 and relevant restriction sites. 
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Figure 3.12. Restriction endonuclease digestion of pDJ4375. Lanes: 1) 1 kb plus ladder; 2) Apa I 
digestion; 3) Pst I digestion. Samples were electrophoresed through 0.8% agarose gel and visualised 
using ethidium bromide staining and UV light (see section 2.4.4). 
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pDJ4375 




5' lex2B 3' 
5' 1:\3' Km pBIISK + 1:\5' 3' 
Figure 3.13. Allelic exchange of a truncated copy of lex2B. Through a single cross, homologous 
recombination event. Homologous recombination should only happen between the lex2B allele (orange 
rectangle) on the C. jejuni 928 chromosome and the truncated lex2B allele harboured on (red) pDJ4375. 
The resulting lex2B recombinant (928Iex2E) would have mismatched 5' and 3' ends (eg., in one instance 
the 5' end will be provided by the plasmid allele and the 3' end from the chromosomal allele. 
Abbreviations: Km= kanamycin 200; pBliSK += suicidal plasmid; II indicates that actual size of 
expression plasmid is 2.96 kb. 
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3.6 lex2B IN OTHER C.jejuni AND C. coli STRAINS 
Yates (1998) determined, using PCR-RFLP analysis, that 5,85% of 105 analysed C. 
jejuni and C. coli isolates produce an ~1.7 kb arnplicon when amplified with the 
oligonucleotide primers 96.01 and 94.293 (see Table 2.4). These isolates were classified 
as the gmhA 3 RFLP profile. To permit a wider examination of lex2B in other C. jejuni 
and C. coli strains, PCR, Southern and dot hybridisation analyses were applied. Strains 
from gmhA group 3(see Table 2.2), including C. jejuni strain 928, and NCTC11168 
were amplified using primers 96.01 and 94.293. All strains (except NCTCll J 68) 
produced a 1.7 kb amplicon. After hybridisation of lex2B probe (see section 2.9.2) a 
signal was detected with all PCR products, again with the exception of NCTC11168 
(Figure 3.14). These results suggested that it is likely that these strains possess lex2B on 
their chromosomes. 
To confirm these results and to develop a rapid method for screening Campylobacter 
isolates for lex2B, dot blot hybridisation analysis was attempted (Figure 3.15). 
Chromosomal DNA (final concentration 10 ng/).LI) from 17 bacterial strains were 
manually applied onto a nylon membrane and hybridised with the lex2B probe. 
Consistent with the previous hybridisation results (pCR amplicons), strains 928 and 
LG430I provided detectable signal. C. coli M275 DNA and the positive control, 
pDJ4216 were also positive. However, PCR positive but dot-blot negative strains (i.e., 
C. jejuni strains YPS02F, MB617B, ZP028D and C. coli RCI67B) suggests that tillS 
method is not completely operational. Unfortunately time constrains prevented a 
completion of this technique. 
An alternative way to rapidly screen C. jejuni strains for the presence of lex2B was to 
create a mono specific polyclonal antibody for lex2B for use in a Western hybridisation 
experiment. In order to achive this Lex2B protein was expressed in E. coli. 
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1.6 kb 
Figure 3.14. Southern hybridisation analysis of PCR products derived from chromosomal DNA of 
different C. jejuni and C. coli strains. Lanes: 1) C. jejuni 928; 2) C. jejuni NCTC11168; 3) C. jejuni 
YP502F; 4) C. jejuni MB617B; 5) C. jejuni LG430I; 6) C. jejuni ZP028D; 7) c. coli RC167B; 8) PCR 
negative. 
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Figure 3.15. Detection of the lex2B gene in different bacterial strains. Dot-blot analysis was perfonned 
with the lex2B probe (see section 2.9). Lanes: 1) C. jejuni 928; 2) YP502F; 3) MB617B; 4) LG430I; 
5) ZP028D; 6) KLC4303; 7) KLC4305; 8)KLC4297; 9) KLC4315; 10) c. coli RC167B; 11) c. coli 
M275; 12) NCTC11168; 13) F38011; 14) E. coli KLC4157; 15) H pylori; 16) Saccharomyces 
cerevisiae; 17) S. typhimurium; 18) pDJ4216 
3.7 Lex2B PROTEIN EXPRESSION 
Expressing large amounts of protein from cloned genes introduced into E. coli has 
proven invaluable in the purification, localisation and functional analysis of proteins. To 
study the expression of lex2B and create a mono specific polyclonal antibody, pET 
vectors and E. coli strain KLC4166 (see Table 2.3, Table 2.1, section 2.8.1) were used. 
The SstI and XhoI restriction sites (GAGCT/C and C/TCGAG) in the multiple cloning 
cassette ofpET24b were used to create an in frame fusion protein of Lex2B (see section 
2.5). The resulting plasmid, pIT<P030 (courtesy of J.D. IGena), contained a fusion of the 
lex2B gene with the initiation codon of the phage gene 10 leader sequence encoded in 
pET24b (Figure 3.16). The fusion gene was under the T7 promoter control. In 
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BL21(DE3)pLysS E. coli, T7 RNA polymerase is under control of pLysS plasmid 
which encodes T7 lysozyme, a natural inhibitor of T7 RNA polymerase. Upon IPTG 
induction, overproduction of T7 RNA polymerase renders low-level inhibition by T7 
lysozyme. The T7 promoter is not recognised by the host cell RNA polymerases, so 
transcription of target gene is silent when no T7 RNA polymerase is present in the cell. 
Plasmid pJKP030 was used to transform KLC4166, resulting in production of the new 
strain KLC4377. The plasmid was reisolated and digested again to verify its structure 
(data not shown). KLC4377 and two control strains KLC4l66 and KLC4171 (see Table 
2.1) were subj ected to a time course expression experiment. KLC4171 contains the 
vector, pETlla, derived from the same origin as pET24b. This strain was used as a 
control for expression of vector encoded genes lacking the fusion protein. After growing 
until OD600 was ~0.4-0.6, production of the fusion protein was induced by adding IPTG 
to the cultures (see section 2.8.1). Results obtained after SDS-PAGE electrophoresis had 
shown that after a 30 minute IPTG induction, production of Lex2B began (Figure 3.17). 
Calculated molecular mass of this protein was approximately 27 IcDa. After 5 hours an 
approximately 4.3 fold increase was witnessed in total protein concentrations (see Table 
3.7.1). Total protein concentration measured after 24 h upon induction with IPTGdid 
not shown further increases in Lex2B concentration. A possible explanation for this 
result is the saturation of the culture after overnight incubation. SDS-PAGE analysis of 
samples collected from uninduced and induced control cultures KLC4166 and 
KLC4171 did not show a protein band of 27 lilla, as expected, due to absence of fusion 
protein on pETl1 a (Figure 3.18). 
This experiment shows that the lex2B was expressed in KLC4377 E. coli under T7 
promoter transcription control. This fusion protein was further used to create a 
polyc1onal antibody for lex2B by elution of protein, purification and then injection of a 
rabbit. At present, lex2B polyc1onal antibody is under development in the laboratory of 
M. Konkel (Washington State University). 





Figure 3.16. Physical map of pJKP030. pJKP030 is estimated to be 5.95 kb, showing direction of· 






Figure 3.17. Electrophoretic analysis of protein extractions from KLC4377 (harbouring pJKP030) in 
IPTG induced time course experiment. Protein extractions were resolved in a SDS-15% polyacrylamide 
gel (SDS-PAGE) using tricine buffer system and visualised by Commassie Brilliant Blue staining as 
described in section 2.8.1. Lanes: 1) low molecular weight marker; 2) uninduced KLC4377; 3) 30 min 
after IPTG induction; 4) 60 min; 5) 90 min; 6) 120 min; 7) 180 min; 8) 4 h; 9) 5 h; 10) 24 h after 
induction. 





Figure 3.18. Electrophoretic analysis of protein extractions from KLC4166, KLC4171 (harbouring 
pET11a) and KLC4377. Proteins were resolved in a SDS-15% polyacryamide gel (SDS-PAGE) using a 
tricine buffer system and visualised by Commassie Brilliant Blue staining as described in section 2.8.1. 
Lanes: 1) low molecular weight marker; 2) KLC4166 uninduced; 3) KLC4166 24 h upon IPTG induction; 
4) KLC4171 uninduced; 5) KLC4171 24 h upon IPTG induction; 6) KLC4377 uninduced; lanes 7,8,9,10) 
KLC4377 30 min, 3 h, 5 hand 24 h after IPTG induction. 
Table 3.2 Protein concentration measured by the method of Bradford. 
TIME 
0' 60' 90' 120' 180' 3h 4h 5h 24h 
KLC4166 0.358 * 2.148 
KLC4171 0.544 2.154 
KLC4377 0.446 0.947 1.230 1.394 1.574 1.802 1.927 2.038 2.055 
* All concentrations are mg/ml 
CHAPTER IV 
DISCUSSION 
In recent years C. jejuni has been an object of intensive research since it is a major cause 
of human gastroenteritis and a significant factor in cases of neurological disorders such 
as GBS and MFS (Salloway et. ai., 1996). LPS and LOS constituents of the outer 
membrane of Gram-negative organisms such as C. jejuni have been shown to be 
important virulence factors for causing infection. These molecules confer, amongst 
other things, serum resistance, antibiotic resistance and endotoxic properties on the 
bacterium (Rietschel and Brade, 1994). Studies involving other bacterial species suggest 
that antigenic and phase variation of LPSILOS epitopes is an adaptive strategy for 
microbial evasion of host immune defensive systems. Whether this strategy is important 
for C. jejuni will be discussed below. 
4.1 lex2B Shows Genomic Diversity 
Upritchard (1997) established that the C. coli isolate M275 has an ORF located 
downstream from the gmhA gene that has significant amino acid sequence similarity 
with the lex2B gene from H injluenzae. This ORF was located between genes whose 
products are predicted to be involved in biosynthesis (gmhA) and assembly (waaF) of 
the LPS core region. In a separate study Yates (Yates, 1998), using gmhA as genetic 
marker to differentiate between C. jejuni and C. coli isolates, found that only a small 
percentage of human C. jejuni isolates might carry this gene. In this study I have 
isolated and characterised a C. jejuni strain 928 gene with a simihir location to the lex2B 
gene in C. coli. Based on data generated in this thesis, I have subsequently named this 
gene lex2B. I have also shown, by peR analysis using oligonucleotides specific for 23S 
rRNA and cadF, that 928 is indeed a C. jejuni isolate (Eyers et. ai., 1993; Konlcel et. ai., 
1999a). 
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Analysis of sequence data generated for a 1.7 kb PCR amplicon from C. jejuni 928 
revealed the presence of two complete and one partial ORF. The first complete ORF of 
561 nucleotides was capable of encoding a protein of 186 amino acids and had mol% 
(G+C) typical for C. jejuni genes (Nuijten et. al., 1990). At the nucleotide level, this 
ORF showed little sequence similarity to the gmhA genes of E. coli and H injluenzae, 
but displayed 94% identity with gmhA from C. jejuni NCTC11168 and 86% with gmhA 
from C. coli M27 5. The predicted amino acid sequence displayed a greater degree of 
similarity to the E. coli gmhA gene, however. Conservation of the predicted GmhA 
protein among C. jejuni and C. coli species is extremely strong showing 98% identity 
between amino acid sequences. These results suggest that considerable nucleotide 
divergence between species is acceptable as long as the primary amino acid structure 
remains conserved (Dykhuizen, 1991). Analysis of interspecies-complementation (see 
section 3.1.2) and sequence data indicates that the first C. jejuni 928 gene contained 
within pDJ4216 is a functional homolog of the E. coli gmhA gene and encodes a product 
with glyceromannophosphate isomerase activity in E. coli K12 . 
. Brooke et al. (1996) suggested the GmhA of E. coli is a cytosolic protein based on 
sequence analyses, but secondary structure prediction of GmhA from C. coli M275 
revealed the presence of a transmembrane helix. This suggests that the protein is most 
likely membrane associated. A transmembrane helix within the GmhA protein was also 
reported for Synechocystis spp. (Kaneko et. al., 1996). 
A second ORF, downstream of the double termination codon of the C. jejuni 928 gmhA, 
contained 765 nucleotides capable of encoding 255 amino acids. Codon usage (data not 
shown) of deduced 255 amino acids and mol% (G+C) content showed strong AT 
richness (74.5%), with a high percentage of hydrophobic amino acids (e.g. Phe, He, 
Lys). This mol% (G+C) is not usual among other bacteria except in some pathogenicity 
islands (Alm et. al., 1999). Considering that the whole C. jejuni genome is AT-rich 
(64%) this mol%(G+C) is not unusual. There are other functional genes in C. jejuni 
reported to have mol% (G+C) slightly under this typical level (e.g. daB). This suggests 
that the ORF have been recently acquired from another bacterial species by a horizontal 
transfer event. An example of .a recent gene acquisition in E. coli demonstrating this 
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phenomenon is waaS, which has a significantly lower mol% (G+C) content than OS and 
KDO pathway genes (Brooke and Valvano, 1996). 
At an amino acid level, the second ORF was shown to have a high degree of identity 
with Lex2B protein from H injluenzae. This homology was extremely strong in three 
regions (overall 74% similarity). Lex2B in H injluenzae is located in the lex-2 locus. In 
this locus, it is transcribed along with a second gene, lex2A. The order of the two genes 
in the operon is lex2A-lex2B. Mutational analysis of the lex-2 locus indicated that 
expression of lex2B is essential for synthesis of a specific LOS epitope. This is reflected 
in the fact that lex2B+ strains react with monoclonal antibodies (MAb) 4C4 and 5G8. 
Extensive identity/similarity was observed with Lex2B of H pylori. This is not 
suprising considering that Helicobacter has also AT rich genome. 
Genes from other bacteria that showed a certain degree of similarity with the putative 
lex2B from C. jejuni 928 (i.g., lobi, IgtB, IgtE, lic2B) are almost exclusively glycosyl 
transferases involved in biosynthesis of OS outer domain of LPSILOS. These genes are 
also phase variable. RCA analysis revealed that lex2B has a motif, D30-4°EDD90-110 
(where the numbers refer to the location of amino acids in the polypeptide sequence) 
, characteristic for processive sugar transferases. Comparison between nucleotide and 
amino acid sequences of lex2B from C. jejuni 928 and C. coli M275 revealed divergence 
that is unexpected for what appears to be an homologous gene in two species from the 
same genus. The amino acid region near the C-terminus of the lex2B gene product is 
especially variable, suggesting that this part of gene is a place of frequent 
recombination. This divergence also suggests that lex2B is an acquired gene from 
another bacterial species. Differences in nucleotide sequence could reflect either 
multiple acquisition events or species-specific changes that have occurred over time. 
Southern hybridisation experiments determined that the C. jejuni 928 lex2B gene is 
present on the chromosome as a single copy. The same analysis confirmed previous 
speculation, based on nucleotide sequencing and PCR-RFLP typing, that C. jejuni 
NCTC11168 is without lex2B. Absolute conformation of the absence of lex2B in C. 
jejuni NCTC11168 has been provided by the complete genome sequence (Sanger centre, 
1998). The lex2B nucleotide sequence was compared with the genomic sequence of 
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NCTCll168 and no significant similarities/identities were uncovered. This suggests 
that appearance of lex2B is not the rule for C. jejuni isolates. 
The third gene transcribed in an opposite orientation from gmhA and lex2B and which 
overlaps the putative lex2B sequence has been shown to contain a functional homolog of 
the S. typhimurium waaF (heptosyl transferase II) gene. This arrangement of genes, 
gmhA-lex2B-waaF, has only been reported for C. coli M275 to date, thus this 
arrangement appears to be Campylobacter specific. However, in C. jejuni strains 
missing the lex2B gene, gmhA is physically linked with waaF, based on previous 
sequence analyses. Further, organisation of gmhA appears to be different depending 
_ upon the organism studied. Many of the genes necessary for LPS core biosynthesis in E. 
coli are located in the large waa operon at 81 minutes on chromosome (Schnaitman and 
lUena, 1993). The genes gmhD, waaF and waaC which are required for biosynthesis 
and attachment of heptose are in one region of the cluster. The E. coli K12 gmhA has 
been reported to be physically unlinl(ed to this cluster, mapping at 5.3 minutes on the 
chromosome (Brooke and Valvano, 1996). GmhA is linl(ed in H ducreyi and H 
injluenzae with genes involved in dipeptide (dpp) transport and arginine uptake (apt). 
Finally, it is interesting to speculate on the organisation of waaF in relationship to gmhA 
and lex2B genes. Perhaps the organisation of these genes in a tail to tail fashion 
represents a means of genetic regulation of heptose attachmentlbiosynthesis of the LPS 
core, the presence of larger operons allowing expression in concert. 
To develop a rapid method for screening large numbers of C. jejuni isolates for the 
presence of lex2B, dot-blot analysis was used. Results were inconsistent; all isolates that 
were shown to amplify a 1.7 kb amplicon by PCR (Yates, 1998) and to contain lex2B by 
probe hybridisation to these PCR amplicons (this study) did not always yield a positive 
result in the dot blot analysis. Possible explanations for these inconsistencies are poor 
application of genomic DNA to the nylon membrane or concentrations of genomic DNA 
were too low to be detected by this method. Unfortunately time constraints did not 
permit full development of this method. However it is clear that lex2B is present in only 
a small percentage of C. jejuni strains. A recently reported gene, orjE, involved in 0-
chain biosynthesis of C. jejuni NCTCl1168 was also found to present in only a small 
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percentage of C. jejuni strains, independent of serotype (Wood et. al., 1999). Mutation 
analyses of this gene had no detectable effect on LOS phenotype in N CTC 11168 but did 
affect, when added to C. jejuni NCTC11828, O-chain production within the LPS. This 
raises the speculation that increasing rates of human infection with C. jejuni could be 
connected with changes in LPS. 
4.2- REGULATION OF lex2B EXPRESSION 
As stated above, the lex-2 locus in H injluenzae encodes two genes, lex2A and lex2B. 
The promoter for this locus is situated 114 bp upstream of the lex2A 5' end. The lex2A 
contains 18 tandem repeats of the nucleotide tetramer GCAA near its 5' end. The 
presence of these repeats provides the opportunity for slipped-strand mispairing, which 
alters the number of tandem repeats and thereby affects expression of these genes. 
Subsequently, the LOS epitopes reactive with MAb 4C4 and 5G8 are altered in such a 
fashion that these MAbs are no longer reactive. The presence of the LOS epitope 
reactive with MAb 5G8 has been correlated with virulence expression in some strains of 
H injluenzae. Mutation analysis has not shown if lex2A is required for expression of 
lex2B (Jarosik and Hansen, 1994). Nucleotide sequencing of the putative lex2B from C. 
jejuni 928 has not revealed the presence of repeated tandem residues within itself of 
within the gmhA gene suggesting that lex2B must have different regulation system than 
the one reported for lex2B from H injluenzae. 
Inspection of the nucleotide sequence upstream of the gmhA initiation site and within 
gmhA in pDJ4216 failed to reveal potential-35 and -10 consensus promoter sequences 
for lex2B transcription. This was not unexpected as the gmhA and lex2B nucleotide 
sequences overlap, suggesting that they may be cotranscribed. While no promoter was 
located upstream of gmhA either, analysis of the nucleotide sequence from NCTCl1168 
suggests that a promoter may be located further upstream (Vasan, D., M.Sc. thesis, 
1999). Current research in our laboratory indicates that promoter sequence for gmhD-
gmhBIC-gmhA is upstream of gmhD. Considering that lex2B is transcriptionaly and 
physically connected with gmhA, I speculate that this promoter also regulates 
transcription of lex2B. Investigation of possible transcriptional and translation 
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connection of lex2B with upstream genes gmhA, gmhBIC andgmhD, using RT-PCR did 
not show that these genes are transcribed from the same promoter (see section 3.4) 
Further experiments using more appropriately designed primers are necessary to assess 
this issue in more detaiL 
4.3 EXPRESSION ANALYSES OF lex2B 
In recent years, the ability to produce and quantitate mRNA has become invaluable as a 
tool to monitor gene expression. To assess expression of the lex2B gene, production of 
mRNA was monitored. Total RNA isolated from C. jejuni 928 and C. jejuni 
NCTC1l168 was digested with DNaseI to eliminate any traces of DNA that could 
create a false positive with RT-PCR. Success of this treatment was indicated by the 
absence of amplified products in DNaseI-treated controls. No RT-PCR-amplified 
products were observed in RNaseA-treated samples, verifying that the target nucleic 
acid was RNA. This result suggests the lex2B gene is likely to be functional since it is 
transcribed into mRNA, which results in production of protein. Absence of an 
amplification signal from lex2B in C. jejuni NCTC 11168 supplies further proof that this 
strain does not contain this gene. 
Once mRNA from the lex2B gene was detected, the gene was placed under phage T7 
promoter controL Under transcriptional control of the T7 promoter, overexpression of 
the Lex2B protein was achieved. The detected fusion protein was 27 lilla. However, the 
only conclusion to be drawn from this result is that Lex2B protein may be expressed in 
E. coli; it does not provide any information if Lex2B protein is expressed in vivo in C. 
jejuni. This experiment does permit generation of a monospecific polyclonal antibody. 
The polyclonal lex2B antibody is an effective tool for screening C. jejuni isolates for 
presence of this product and can provide a picture, over time, about how the percentage 
of isolates containing this gene product changes. This antibody can also be used to 
determine if lex2B expression is connected with certain HS (Penner) serotypes. 
Generally, at the organism level, isolates of C. jejuni show considerable heterogeneity in 
the outer LPS core (Aspinall et. al., 1993b). It is tempting to speculate that different 
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levels of gene expression as a result of changes in gene order with recently acquired 
genes (like lex2B) and presence of transcriptional coupling to adjacent genes could 
provide a mechanism for this variation. 
4.4 FUNCTION OF lex2B IN C. jejuni 928 
Serotyping using the Penner method determined that C. jejuni 928 is a member of the 
HSlfHS44 serogroup (the antigen giving higher titer was listed first). This method 
identifies over 60serotypes (at least 44 C. jejuni and 18 C. coli) using LPS as a heat 
stable antigen. Aspinall et al. (1992, 1993a, 1993b, 1993c, 1994, 1995) characterised the 
chemical structure of LPS from serotypes HSl, HS2, HS3, HS4, HSI9, HS23 and 
HS36. Knowing that C. jejuni NCTC11168 is a member of the HS2 serogroup and C. 
jejuni 928 is HSl, I speculated from the lmown LPS chemical structures of these two 
serotypes that the role of the Lex2B protein in LPS biosynthesis could be a galactosyl 
transferase. As Figure 4.1 shows the only difference between the two HS types appears 
to be the presence of GalNAc linked (0.1-4) to the last Gal molecule in nascent OS outer 
core chain. If the lex2B gene product is a sugar transferase as suggested by hydrophobic 
cluster analysis then it is possible that its role is the transfer of GalNAc to the outer 
domain of OS. Similar to HSl, serogroups HS3, HS23 and HS36 also possess GalNAc 
as the last molecule in the LPS chain. Additionally the OS structure of these serotypes 
strongly resembles the human ganglioside GM2• If lex2B is responsible for the transfer of 
this molecule, it is expected that lex2B is present on chromosome of other serotypes 
containing this sugar epitope. Further to this PCR analysis using lex2B primers of HS23 
and HS36 C. jejuni strains showed that it is likely that these serotypes contains lex2B 
since they produce PCR amplicons with lex2B specific primers (data not shown). 
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Figure 4.1. Known structure of core molecules and 0 antigen-like polysaccharides from C. jejuni 
serotypes that contain potential cross-reactive epitopes with different gangliosides. (Adapted from 
Nachamkin, 1998). 
To assess the exact function of lex2B in C. jejuni 928, attempts to create a "null" 
mutant were made. A plasmid construct carrying the truncated lex2B with kanamycin as 
a marker was engineered, but to date all attempts to obtain C. jejuni 928 (lex2B") 
kanamycin resistant isolates have failed. As mentioned previously, one possible 
explanation for this is the poor transformation capacity of C. jejuni. The method used to 
transform C. jejuni cells with a truncated lex2B allele carried on a suicide plasmid has 
been shown to be successful in recent studies (Konkel et. al., 1997). Alteration of the 
protocol for preparing competent C. jejuni cells is under way. At the same time a 
different approach was taken, using a shuttle plasmid containing a Campylobaeter 
origin of replication and lex2B to transform C. jejuni strains showing absence of lex2B 
on their chromosomes (e.g. C. jejuni NCTCI1168). Addition of lex2B in these strains 
should change the LPS structure visible on SDS-PAGE gel and also change serotype 
(i.g., C. jejuni NCTC11168 HS2 would change to HS1). This experiment is also under 
way. 
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4.5 CONCLUSIONS 
In this thesis the isolation and characterisation of the C. jejuni lex2B gene from strain 
928 has been described. This gene appears to encode a galactosyl transferase that may 
be involved in the transfer of GalNAc to the last Gal molecule in the LPS chain. 
The gmhA gene is highly conserved among C. jejuni and C. coli isolates. In a small 
percentage of these isolates gmhA is physically and possibly transcriptionally linked 
with novel gene, lex2B. Codon usage and mol% (G+C) content suggest lex2B has been 
acquired recently by Campylobacter isolates. This gene is a variable feature of the 
Campylobacter spp. genomic landscape. 
Expression of the lex2B gene results in a protein of calculated molecular mass of 27 
kDa. RCA analysis revealed that the lex2B gene product has an amino acid motif 
characteristic for other galactosyl transferases. 
In other enteric and non-enteric bacteria, lex2B is essential for synthesis of LPSILOS 
epitopes. The regulation of lex2B in these organisms is probably through slip strand 
mispairing mechanism. Based on the nucleotide sequence of lex2B and adjoining 
sequences, regulation in C. jejuni does not appear to be through this type of mechanism. 
The speculation that lex2B is a sugar transferase involved in attachment of the last 
modified sugar, GalNAc, to the outer domain of OS remains to be determined as 
outlined previously. 
4.6 FUTURE EXPERIMENTS 
Future experiments include assessing the expression of lex2B over the cell cycle, in 
order to determine if antigenic variation due to Lex2B presence/absence occurs at the 
isolate level. For this purpose mRNA will be isolated from C. jejuni 928 at different 
growth densities and subjected to RT-PCR for the lex2B mRNA. Additionally, the level 
of Lex2B protein can be monitored by Western blot analysis. Design of appropriate 
primers spanning a smaller DNA fragment (i.e., forward primer in gmhA near the 3 'end 
and reverse primer near 5' end of lex2B) should clear the picture regarding the 
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transcription of these two genes. Finally, binding and internalisation assays are 
necessary to define the effect changes in LPS structure_c:aused by lex2B have on the 
. ---
virulence of C. jejuni. These experiments Vvill initially be done in a cell culture assay, 
and if promising, moved to a live animal model (e.g., chicks). 
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APPENDIX I 
MEDIA 
I.i. GENERAL MEDIA 
Unless otherwise stated, all media were sterilised by autoclaving for 20 minutes, 121°C 
at 120 kPa. Solutions that were labile at this temperature were filter-sterilised through a 
0.22 ~m filter prior to addition to sterile media. 
Luria Bertani Medium (LB) 
1.0% w/v Bacto tryptone 
0.5% w/v yeast extract 





Dissolved in dH20, pH adjusted to 7.4 with 2M NaOH before autoc1aving. 
LB Agar (LBA) 
LB media with addition of 1.5% w/v agar 










Dissolved in dH20 and pH adjusted to 7.4 before autoc1aving. 
Nutrient Broth No.2 Agar 
Nutrient Broth No.2 with addition of 1.5% w/v agar 
THE LIBRARY 






30% w/v beef infusion 








Dissolved in dH20 and pH adjusted to 7.4 before autoc1aving. For culturing of 
Campylabaeter, defibrinated sheep blood (S%) was added after autoclaving. 
Brain Heart Infusion Broth Per litre 
Beef heart infusion 2Sg 
Calf brain infusion 20g 




Dissolved in dH20 and pH adjusted to 7.4 before autoclaving. For storage of 
Campylabaeter, 20% glycerol was added to the medium after autoclaving. 
I.ii. SPECIALISED MEDIA 
Campy/obaeter Blood-Free Selective Agar Base (Modified CCDA-Preston) 
Per litre 
Oxoid Campylobacter Blood-Free Selective Agar Base 12.S g 
(Modified CCDA-Preston) 
100 
Dissolved in dH20 and pH adjusted to 7.4 before autoclaving. After sterilisation, 1 mlof 
cefoperasone solution (3.2 mg/l) was added to the medium. 
MacConkey ~edium (Mac) 





BUFFERS AND SOLUTIONS 
II.i. COMlVION BUFFERS 
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Solutions requiring sterilisation were either autoclaved for 20 minutes at 121°C, 120 
kPa or filter-sterilised through a 0.22 J..Lm filter. All solutions were stored at ambient 
temperature unless otherwise stated. 
TE 
10 mM Tris-HCI 
1 mMEDTA 
Dissolved in dH20, pH adjusted to 8.0. 
50 x TAE 
2.5 M Tris base 
0.11 % v/v glacial acetic acid 








Dissolved in dH20 to fmal volume of 1 litre, pH adjusted to 8.0. 
lxTAE 
20 ml of 50 x T AE dissolved in dH20 to a final volume of 1 litre. 
10 x TBE 








Dissolved in dH20 to fmal volume of 1 litre, pH adjusted to 8.0 . 
. 6 x DNA Loading Buffer for Agarose Gel Electrophoresis 
50% v/v Glycerol 
0.25% w/v Bromophenol blue 
0.25% w/v Xylene cyanol FF 
Dissolved in dH20. 
II.ii. SPECIFIC BUFFERS AND SOLUTIONS 
lI.ii.a. ALKALINE EXTRACTION OF PLASl\tIID DNA 
Solution 1 (Stored at 4 DC) 
50 mM glucose 
25 mM Tris-HCI (PH 8.0) 
10 mM EDTA (PH 8.0) 
Dissolved in dH20, autoc1aved to sterilise. 
Solution II 
1% w/v SDS 
0.2NNaOHl 
Dissolved in dH20, not sterilised. 
I Freshly diluted from ION stock 
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Solution III (Stored at 4°C) 
3 M potassium acetate 
11.5% v/v glacial acetic acid 
Dissolved in dH20, resulting solution is 3 M with respect to potassium and 5 M with 
respect to acetate. 
lI.ii.b. ISOLATION OF GENOMIC DNA 
SET buffer 
75 mMNaCI 
25 mM EDTA (PH 7.5) 
20 mM Tris 
II.ii.c. SOUTHERN HYBRIDISATION SOLUTIONS 
Depurination solution 
0.2MHCI 













0.5 M Tris-HCI (PH 7.0) 
3 MNaCl 
Dissolved in dclI-I20, pH adjusted to 7.0. 
20 x sse (Standard Saline Citrate) 
3 MNaCI 
0.3 M Trisodium citrate 
. Dissolved in dclI-I20, pH adjusted to 7.0 with citric acid. 
Transfer Solution 
20 x SSC, pH 7.0 
DIG Buffers and Solutions 
Maleic Acid Buffer 
M maleic acid 
0.15 MNaCI 
pH adjusted to 7.5 with concentrated or solid NaOH 
Washing Buffer 
Add 0.3% v/v Tween 20 to Maleic acid buffer 
Blocking Solution 
10% v/v blocking reagent 
90% v/v maleic acid buffer 









Post-Hybridisation Low Stringency Wash I 
2 x SSC 
0.1% SDS 
Post-Hybridisation High Stringency Wash II 
0.5 x SSC 
0.1% SDS 
Detection Buffer 
M Tris-HC! (PH 9.5) 
MNaCI 
II.H.d. SDS-P AGE FOR PROTEINS 
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To make a 15% acrylamide separating gel and 4% stacldng gel the following volumes of 
solutions were mixed. 
Table ALl. SDS-PAGE protein gel recipies 
AppendixIl 
10%w/vSDS 
sodium dodecyl sUlphate (SDS) 
10 g 
Dissolved in 100 ml ddlliO. 
0.1 % w/v Bromophenol blue 
bromophenol blue 
ddH20 
2 x Sample Buffer 
4 x upper buffer 
glycerol 
Dissolved in ddlliO to a final volume of 60 m!. 
2 x Loading Buffer 
2-~-mercaptoethanol 
0.1 % Bromophenol blue 
10% SDS 
2 x Sample buffer 
4 x Running Buffer Stock 
Tris-base 
glycine 
Dissolved in ddH20 to a [mal volume of 5 litre. 
1 x Running Buffer 
























Added ddH20 to a final volume of 2 litres. 










To malce a 18% acrylamide separating gel and 4.5% stacking gel the following volumes 
of solutions were mixed. 
Table A1.2SDS-PAGE LPS gel recepies 
Appendix II 
Gel Buffer 
4 M Tris-Hel 
O.4%w/v SDS 
per 100 ml 
48.46 g 
0.4 g 
Dissolve with gentle heating in ddfuO, adjust pH to 8.45 with concentrated Hei. 
LPS Running Buffer 
0.1 M Tris-Hel 






Dissolve in ddH20, adjust pH to 8.25 with concentrated Hei. 
IT.li.f. SILVER STAINING SOLUTIONS FOR LPS 
Fixing Solution 
25% v/v isopropanol 
7% v/v glacial acetic acid 
68% v/v ddH20 
Oxidation Solution 
2.7% v/v fixing solution 
0.7% w/v periodic acid 
Prepare solution freshly in ddH20. 
Silver Solution 
28 ml 0.1 N NaOH (dilute 1 N stock) 
1.25 ml NH40H (29.4% stock) 
5 ml 20% AgN03 
115 ml ddH20 
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Citric Acid Developer 
50mg citric acid 
0.5 ml formaldehyde (37% stock) 
Dissolve in 1 litre of ddH20 
Reaction Stop Solution 
0.35% v/v acetic acid 





A. Blast aligments for C. jejuni 928 gmhA 
gb1AAD07903.11 (AE000596) phosphoheptose isomerase (gmhA) 
[Helicobacter pylori26695] 
Length = 192 
Score = 219 bits (552), Expect = 1e-56 
Identities = 113/184 (61%), Positives 142/184 (76%), Frame +1 
Query: 7 NLVEKEWQEHQKIIQES-
EILKGQIAKVGELLCECLKKGGKILICGNGGSAADAQHFAAE 183 




Query: 184 . 
110 
LSGRYKKERKALAGIALTTDTSALSAIGNDYGFEFVFSRQVEALGNENDVLIGISTSGKS 363 






NVL+A++KAK+L M L +G+ GG M L D L+VPSDDT RIQEMHIL+IH LC 
Sbjct: 124 
KNVLKAYEKAKDLEMKTLSLAGRDGGKMKPLSDMALIVPSDDTPRIQEMHILMIHILCDC 183 
Query: 544 IDEGF 558 
I+ F 
Sbjct: 184 IERHF 188 
spIP51001ILPCA_ECOLI PHOSPHOHEPTOSE ISOMERASE >gi19845781dbj1BAA075841 
(D38582) YafI 
[Escherichia coli] >gi11079568 (U32590) phosphoheptose 
isomerase [Escherichia coli] >gi11786416 (AE000131) 
phosphoheptose isomerase [Escherichia coli] 
>gi 149029581 dbj IBAA77892 .11 (D83536) Phosphoheptose 
isomerase (EC 5. - . - . -). [Escherichia coli] 
Length = 192 
Score = 150 bits (376), Expect = 6e-36 











S +GND+GF +FSR VEA+G E DVL+GISTSG S NV++A A+E M + +GK 
Sbjct: 89 
SCVGNDFGFNDIFSRYVEAVGREGDVLLGISTSGNSANVIKAIAAAREKGMKVITLTGKD 148 
Query: 436 GGMMNKLCDHNLVVPSDDTA-RIQEMHILIIHTLCQIIDE 552 
GG M D + VP A RIQE+HI +IH L Q+I++ 
Sbjct: 149 GGKMAGTADIEIRVPHFGYADRIQEIHIKVIHILIQLIEK 188 
B. Blast aligment for C. jejuni928lex2B 
giIS073S4</b></a> (U05670) Lex2B [Haemophilus influenzael 
Length = 247 
Plus Strand HSPs: 
Score = 80 (36.6 bits), Expect = 5.5e-23, Sum P(3) = 5.5e-23 




7 VFIINLERSLDRKEHMKKQIQKLFEKN 87 
+FIINLE+S DRK +M+ Q + LF N 
6 IFIINLEKSTDRKAYMQAQFELLFSNN 32 
140 (64.1 bits), Expect = 5.5e-23, Sum P(3) = 5.5e-23 
Identities = 23/43 (53%), positives = 33/43 (76%), Frame = +1 
Query: 199 GRELSDGEKACFASHYKLWQECVKLDEPIIILEDDVEFSDEFL 327 
G L+ G+ C+ASHY +W++CV+LD PII+LEDD +F + FL 
Sbjct: 67 GYPLTLGQLGCYASHYSMWEKCVELDYPIIVLEDDAKFKNNFL 109 
Score = 85 (38.9 bits), Expect = 5.5e-23, Sum P(3) = 5.Se-23 
Identities = 18/39 (46%), Positives = 22/39 (56%), Frame = +1 
Query: 457 AGTQGYVLQVSAAVKFLKYAKNWIYAVDDYMDMFYKHNV 573 
AG GY L AA KFL +K W VD MD F+++ V 
Sbjct: 155 AGATGYYLTPQAARKFLTQSKEWYLTVDVTMDRFFENKV ~93 
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gil2078280 (U94833) Lob1 [Haemophilus somnus] 
Length 287 
Plus Strand HSPs: 
Score = 66 (30.2 bits), Expect = 9.4e-22, Sum P(3) = 9.4e-22 
Identities = 12/36 (33*), positives = 22/36 (61*), Frame = +1 
Query: 7 VFIINLERSLDRKEHMKKQIQKLFEKNPSLKNKLEF 114 
+F+INLE++ +RK + Q L E++P + +F 
Sbjct: 42 IFVINLEKATERKHFISHQFTALQEQHPDIVINYQF 77 
Score = 132 (60.5 bits), Expect = 9.4e-22, Sum P(3) = 9.4e-22 




199 GRELSDGEKACFASHYKLWQECVKLDEPIIILEDDVEFSDEFL 327 
G E++ G+ C+ASHY LW++CV+L +PII+LEDD FL 
105 GNEITLGQLGCYASHYLLWEKCVQLQQPIIVLEDDAILQPNFL 147 
99 (45.4 bits), Expect = 9.4e-22, Sum P(3) = 9.4e-22 
Identities = 21/50 (42*), positives = 30/50 (60*), Frame = +1 
Query: 
Sbjct: 
457 AGTQGYVLQVSAAVKFLKYAKNWIYAVDDYMDMFYKHNVLNIVKKPLFLK 606 
+ T GY L AA KFL ++ WIY VD +MD FY+++V + P +K 
195 SNTTGYYLTPQAAQKFLDSSQEWIYNVDIFMDRFYENHVALLGVNPPCVK 244 
giI2313935</b></a> (AE000592) lipooligosaccharide 5G8 epitope 
biosynthesis-associated protein (lex2B) [Helicobacter pylori] 
Length = 284 
Plus Strand HSPs: 
Score = 134 (61.4 bits), Expect = 5.0e-16, Sum P(3) = 5.0e-16 
Identities = 22/42 (52%), positives = 30/42 (71%), Frame = +1 
Query: 
Sbjct: 
199 GRELSDGEKACFASHYKLWQECVKLDEPIIILEDDVEFSDEF 324 
G+ + GE C+ASHY LWQ+C++L+E I ILEDD+ D F 
94 GKRMGFGELGCYASHYSLWQKCIELNEAICILEDDIIIKDRF 135 
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Score = 62 (28.4 bits), Expect = 5.0e-16, Sum P(3) = 5.0e-16 
Identities = 13/19 (68%), Positives = 14/19 (73%), Frame = +1 
Query: 
Sbjct: 
460 GTQGYVLQVSAAVKFLKYA 516 
GTQGYVL AA K LKY+ 
182 GTQGYVLAPKAAQKLLKYS 200 
Score = 58 (26.6 bits), Expect = 5.0e-16, Sum P(3) = 5.0e-16 
Identities = 11/,24 (45%), Positives = 13/24 (54%), Frame = +1 
Query: 514 AKNWIYAVDDYMDMFYKHNVLNIV 585 
AK W+ +D MD Y H V N V 
Sbjct: 201 AKEWVMPIDCVMDRHYWHGVKNYV 224 
spIQ50947ILGTB_NEIGO LACTO-N-NEOTETRAOSE BIOSYNTHESIS GLYCOSYL 
TRANFERASE LGTB 
>gi1595811 (U14554) glycosyl transferase [Neisseria 
gonorrhoeae] 
Length = 279 
Score = 35.2 bits (79), Expect = 0.59 
Identities = 35/100 (35%), positives = 49/100 (49%), Frame +1 
Query: 208 LSDGEKACFASHYKLWQECVKLDEP-IIILEDDV---
EFSDEFLNNGVEYIDELLKSKYE 375 
LS EKACF SH LW++ + P I + EDDV E +++FL + 
Sbjct: 58 
LSGVEKACFMSHAVLWEQALDEGVPYIAVFEDDVLLGEGAEQFLAEDTWLQERFDPDSAF 117 
Query: 376 YIRLCYLFDKRLYFLSESG--------YYLSIEKLAGTQGYVLQVSAAVKFL 507 
+RL +F L S SG + L + GT GY++ A FL 
Sbjct: 118 VVRLETMFMHVL--TSPSGVADYGGRAFPLLESEHCGTAGYIISRKAMRFFL 167 
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spIQ51117ILGTE_NEIME LACTO-N-NEOTETRAOSE BIOSYNTHESIS GLYCOSYL 
TRANFERASE LGTE 
>gi1973187 (U25839) glycosyl tranferase [Neisseria 
meningitidis] >gi11586B031prfl 12204376C 19tE gene 
[Neisseria meningitidis] 
Length = 276 
Score = 36.7 bits (B3), Expect = 0.20 
Identities = 31/101 (30%), Positives = 50/101 (4B%), Frame +1 
Query: 20B 
LSDGEKACFASHYKLWQECVKLDEPIIILEDDVEFSDEFLNNGVEYIDELLKSKYEYIRL 3B7 




Query: 388 CYLF-------DKRLYFLSESGyyLSIEKLAGTQGYVLQVSAAVKFLK 510 
+F DK L + + S L E GT GY++ A FL+ 
Sbjct: 11B ETMFAKVIVRPDKVLNYENRSFPLLESEHW-GTAGYIISREAMRFFLE 164 
C Blast aligment for waaF' 
splp37692IRFAF_ECOLI ADP-HEPTOSE--LPS HEPTOSYLTRANSFERASE II 
>gill0735B61pirlls47841 
rfaF protein - Escherichia coli >gi1466758 (U00039) rfaF 
[Escherichia coli] >gi11790050 (AE000440) 
ADP-heptose--lps heptosyltransferase IIi 
lipopolysaccharide core biosynthesis [Escherichia coli] 
Length = 348 
Score = 44.9 bits (104), Expect = le-04 





++ +TNDSG MH++A V ++GP+ T P ++ AR + L+ 
Sbjct: 263 KAIVTNDSGLMHVAAALNRPLVALYGPSSPDFTPPLSHK-
ARVIRLITGYHKVRKGDAAE 321 
Query: 66 KHHKCMKDLKPQRVIEE 82 
+H+ + D+ PQRV+EE 
Sbjct: 322 GYHQSLIDITPQRVLEE 338 
spIP37421IRFAF_SALTY ADP-HEPTOSE--LPS HEPTOSYLTRANSFERASE II 
>gi1459161 (U06472) 
ADP-heptose:LPS heptosyltransferase II [Salmonella 
typhimuriuml 
Length = 348 
Score = 44.5 bits (103), Expect = 2e-04 
+ 
Identities = 24/77 (31%), positives = 42/77 (54%), Gaps = 1/77 (1%) 
Query: 6 
RSFLTNDSGPMHLSAVYKVKTVVIFGPTKFTQTSPWQNQNARWVHLVLACMPCMQKTCPL 65 
++ +TNDSG MH++A V ++GP+ T P ++ AR + L+ 
Sbjct: 263 KAIVTNDSGLMHVAAALDRPLVALYGPSSPDFTPPLSHK-
ARVIRLITGYHKVRKGDTAQ 321 
Query: 66 KHHKCMKDLKPQRVIEE 82 
+H+ + D+ PQRV+EE 
Sbjct: 322 GYHQSLIDITPQRVLEE 338 
+ 
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